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Figure S-1. Structure of complex 12b (L = XPhos) in the solid state; only the complex cation is depicted, 
whereas the escorting [NTf2]
 anion as well as co-crystallized CH2Cl2 are omitted for clarity. 
Figure S-2. Structure of complex 12c (L = SIPr) in the solid state; only the complex cation is depicted, 
whereas the escorting [NTf2]
 anion as well as co-crystallized CH2Cl2 are omitted for clarity 
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Figure S-3. Structure of complex 15 in the solid state; only the complex cation is depicted for clarity 
X-ray Crystal Structure Analysis of Complex 12b: C74H109Au2Cl2F6NO5P2S2, Mr = 1797.52 g·mol
-1, colorless 
needle, crystal size 0.23 x 0.05 x 0.04 mm, monoclinic, space group P21/c, a = 14.610(3) Å, b = 19.683(4) 
Å, c = 27.269(5) Å,  = 100.485(3)°, V = 7711(3) Å3, T = 100 K, Z = 4, Dcalc = 1.548 g·cm
3,  = 0.71073 Å, 
(Mo-K) = 4.028 mm-1, Multi-Scan absorption correction (Tmin = 0.49, Tmax = 0.88), Bruker-AXS Kappa
Mach3 APEX-II diffractometer, 1.75 <  < 27.50°, 176078 measured reflections, 17692 independent 
reflections, 15300 reflections with I > 2(I); structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.030 [I > 2(I)], wR2 = 0.079, 856 parameters, H atoms riding, S = 
1.041, residual electron density +2.7 / 1.5 e Å-3. CCDC 1417652 
X-ray Crystal Structure Analysis of Complex 12c: C61.64H86.27Au2Cl1.27F6N5O5S2, Mr = 1594.32 g·mol
-1, 
colorless plate, crystal size 0.24 x 0.17 x 0.06 mm, orthorhombic, space group Pbca, a = 22.049(4) Å, b = 
23.9661(14) Å, c = 25.927(5) Å, V = 13700(4) Å3, T = 100 K, Z = 8, Dcalc = 1.546 g·cm
3,  = 0.71073 Å, 
(Mo-K) = 4.453 mm-1, Multi-Scan absorption correction (Tmin = 0.40, Tmax = 0.73), Bruker AXS Enraf-
Nonius KappaCCD diffractometer, 2.63 <  < 35.01°, 264725 measured reflections, 30068 independent 
reflections, 21100 reflections with I > 2(I); structure solved by direct methods and refined by full-
matrix least-squares against F2 to R1 = 0.041 [I > 2(I)], wR2 = 0.102, absolute structure parameter = 
0.2(6), 813 parameters, H atoms riding, S = 1.120, residual electron density +2.6 / 2.4 e Å-3. CCDC 
1417653 
X-ray Crystal Structure Analysis of Complex 15: C51H44Au2F6N2O6P2S2, Mr = 1414.88 g·mol
-1, colorless 
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plate, crystal size 0.09 x 0.08 x 0.02 mm, triclinic, space group P1¯, a = 12.074(3) Å, b = 14.204(3) Å, c = 
16.028(3) Å,  = 80.320(4)°,  = 85.057(4)°,  = 67.709(4)°, V = 2506.6(9) Å3, T = 100 K, Z = 2, Dcalc = 1.875 
g·cm3,  = 0.71073 Å, (Mo-K) = 6.067 mm
-1, Multi-Scan absorption correction (Tmin = 0.57, Tmax = 0.89),
Bruker-AXS Kappa Mach3 APEX-II diffractometer, 1.29 <  < 31.03°, 73431 measured reflections, 15987 
independent reflections, 13402 reflections with I > 2(I); structure solved by direct methods and refined 
by full-matrix least-squares against F2 to R1 = 0.022 [I > 2(I)], wR2 = 0.058, 643 parameters, H atoms 
riding, S = 1.085, residual electron density +1.4 / 1.3 e Å-3. CCDC 1417651 
General. All reactions were carried out under Ar in flame-dried glassware. The solvents were purified by 
distillation over the indicated drying agents and were transferred under Ar: THF, Et2O (Mg/anthracene), 
MeCN, CH2Cl2 (CaH2), MeOH (Mg), hexane (Na/K), toluene (Na/K). DMF, pyridine and NEt3 were dried by 
an absorption solvent purification system based on molecular sieves. HMPA and iPr2NH were purified by 
distillation over CaH2 and transferred under Ar. CH3NO2 and HOAc were used as received. Flash 
chromatography: Merck silica gel 60 (40–63 μm). NMR: Spectra were recorded a Bruker DPX 300, AV 
400, AV 500 or AV 600 spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm 
relative to TMS, coupling constants (J) in Hz. The solvent signals were used as references and the 
chemical shifts converted to the TMS scale (CDCl3: δC ≡ 77.16 ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 
ppm; CD2Cl2: δC ≡ 53.84 ppm; residual CH2Cl2 in CD2Cl2: δH ≡ 5.32 ppm; C6D6 H ≡ 7.15 ppm, C ≡ 128.00 
ppm; [D6]-DMSO: H ≡ 2.50 ppm, C ≡ 39.5 ppm; [D5]-pyridine: H ≡ 8.74, 7.58, 7.22 ppm, C ≡ 150.35, 
135.91, 123.87 ppm; D3COD: H ≡ 3.31 ppm, C ≡ 49.00 ppm). IR: Spectrum One (Perkin-Elmer) 
spectrometer, wavenumbers (?̃?) in cm-1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ 3000 
(Bruker), accurate mass determinations: Bruker APEX III FT-MS (7 T magnet) or MAT 95 (Finnigan). 
Unless stated otherwise, all commercially available compounds (ABCR, Acros, Aldrich, Strem) were used 
as received. TeocCl,1 (E)-1,1-dibromopenta-1,3-diene,2 and [LAuNTf2]
3 (L = PPh3, SPhos, XPhos, SIPr) 
were prepared in analogy to literature procedures. 
Gold Complexes 
Representative Procedure for the Preparation of gem-Diaurated Complexes. Preparation of Complex 
12a (L = PPh3). [(Ph3P)AuNTf2] (828 mg, 1.12 mmol) was added to a solution of compound 10 (114 mg, 
0.56 mmol) and Cs2CO3 (182 mg, 0.56 mmol) in THF (5 mL) and the resulting mixture was stirred at 
ambient temperature for 1 h. At this point, inspection of the reaction mixture by 31P NMR showed the 
formation of a major product (P = 37.1 ppm, ca. 90 %), together with small amounts of unreacted 
[(Ph3P)AuNTf2] (P = 31.0 ppm, ca. 7 %) and [(Ph3P)2Au][NTf2] (P = 45.3 ppm, ca. 3 %). For work up, all 
volatile materials were distilled off under vacuum (15 mbar) and the residue was passed through a short 
silica gel column (ca. 10 cm,  2 cm), eluting with CH2Cl2 (200 mL). The combined product-containing 
fractions were evaporated and the residue dried in vacuo to give complex 12a as a colorless oil (383 
mg), which contained trace impurities of [(Ph3P)2Au][NTf2] and (Ph3P)AuCl (likely formed by activation of 
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cooling a solution of the complex in CH2Cl2, layered with cold pentane, to –78°C. 
1H NMR (400 MHz, 
CD2Cl2):  = 7.70 – 7.33 (m, 30-35H),
4 7.30 (s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 2.09 (q, J = 1.5 Hz, 3H), 1.43 (t, 
J = 7.1 Hz, 3H); 13C NMR (100 MHz, CD2Cl2):  = 174.8 (t, 
3JPC = 2.4 Hz), 134.4 (d, 
2JPC = 13.8 Hz), 132.5 (d, 
4JPC = 2.6 Hz), 129.8 (d, 
3JPC = 11.5 Hz), 129.3 (d, JPC = 56.7 Hz), 120.4 (q, JCF = 322 Hz), 116.6 (t, JPC = 60.6 
Hz), 71.8, 20.3, 15.4; 31P NMR (162 MHz, CD2Cl2):  = 37.5; MS (ESI): m/z 1003 (M
+ – NTf2); 721 
[(Ph3P)2Au
+]; 280 (NTf2
-); HRMS (ESI): m/z: calcd. for C41H39Au2OP2 [M
+]: 1003.1801, found: 1003.1792. 
The following complexes were prepared analogously: 
Complex 12b (L = XPhos): colorless solid (142 mg, 87%); crystals suitable for X-ray diffraction were 
grown from CH2Cl2/pentane; 
1H NMR (400 MHz, CD2Cl2): δ = 7.69 – 7.61 (m, 2H), 7.54 – 
7.46 (m, 4H), 7.05 – 6.99 (m, 4H), 6.97 (d, J = 1.7 Hz, 2H), 6.24 (s, 1H), 4.07 (q, J = 7.1 
Hz, 2H), 2.88 (sept., J = 6.9 Hz, 2H), 2.39 (sept., J = 6.7 Hz, 4H), 2.22 (sept., J = 6.7 Hz, 
2H), 2.20 – 1.63 (m, 24H), 1.37 (t, J = 7.1 Hz, 3H), [1.48 – 1.06 (m), 1.31 (d, J = 6.9 Hz), 
1.28 (d, J = 6.9 Hz), 1.22 (d, J = 6.9 Hz), 1.17 (d, J = 6.9 Hz), 42H], 0.94 (d, J = 6.7 Hz, 6H), 0.93 (m, 3H), 
0.86 (d, J = 6.7 Hz, 6H); 13C NMR (100 MHz, CD2Cl2): δ = 169.8 (t, 
3JPC = 1.8 Hz), 149.2, 147.5 (d, JPC = 15.2 
Hz), 147.0, 146.8, 136.4 (d, JPC = 5.4 Hz), 134.8 (d, JPC = 8.4 Hz), 133.6, 131.2 (d, JPC = 2.2 Hz), 127.8 (d, JPC 
= 6.8 Hz), 126.8 (d, JPC = 45.8 Hz), 122.2, 121.5, 120.4 (d, JCF = 320 Hz), 117.2 (t, JPC = 58.7 Hz), 70.6, 38.4 
(d, JPC = 28.8 Hz), 37.4 (d, JPC = 30.4 Hz), 34.2, 31.6 (d, JPC = 3.9 Hz), 31.3, 31.1, 30.6, 30.4, 30.3, 27.44 (d, 
JPC = 11.8 Hz), 27.39 (d, JPC = 13.2 Hz), 27.01 (d, JPC = 12.5 Hz), 26.95 (d, JPC = 13.5 Hz), 26.4, 26.2, 25.4, 
25.3, 24.5, 23.8, 23.3, 22.9, 20.3, 15.4; 31P NMR (162 MHz CD2Cl2): δ = 38.7; MS (ESI): m/z 1431 [M
+ - 
NTf2]; HRMS (ESI): m/z calcd for C71H107Au2OP2 [M
+ - NTf2]: 1431.7123, found: 1431.7113;  
Complex 12c (L = SIPr): pale yellow solid (141 mg (73%); crystals suitable for X-ray diffraction were 
grown from CH2Cl2/pentane; 
1H NMR (600 MHz, CD2Cl2): δ = 7.38 (t, J = 7.7 Hz, 4H), 
7.16 (d, J = 7.7 Hz, 8H), 5.31 (q, J = 1.4 Hz, 2H), 3.95 (s, 8H), 3.54 (q, J = 7.1 Hz, 1H), 
[2.90 (sept., J = 6.9 Hz), 2.89 (sept., J = 6.9 Hz) 8H], 1.250 (d, J = 6.9 Hz, 12H), 1.247 (d, J 
= 6.9 Hz, 12H), 1.06 (d, J = 6.9 Hz, 12H), 1.05 (t, J = 7.1 Hz, 3H), 1.03 (d, J = 6.9 Hz, 12H), 
0.51 (d, J = 1.4 Hz, 3H); 13C NMR (150 MHz, CD2Cl2): δ = 206.4, 170.1, 146.99, 146.92, 134.6, 130.0, 
124.78, 124.73, 120.3 (q, JCF = 322 Hz), 103.9, 70.0, 54.1, 29.12, 29.02, 25.04, 24.97, 24.40, 24.15, 19.4, 
15.3; MS (ESI): m/z 1259 [M+ - NTf2]; 280 [NTf2
-]; HRMS (ESI): m/z: calcd. for C59H85Au2N4O [M
+ - NTf2]: 
1259.6049, found: 1259.6062. 
Complex 14. A solution of boronate 13 (227 mg, 0.66 mmol),5 Cs2CO3 (215 mg, 0.66 mmol) and 
(Ph3P)AuNTf2 (488 mg, 0.66 mmol) in THF (3 mL) was stirred for 2 h before all volatile 
materials were evaporated. The residue was suspended in CH2Cl2 (3 mL), insoluble 
materials were filtered off and the filtrate was evaporated. The residue was suspended 
in pentane (10 mL) and the suspension stirred for 1 h. Insoluble materials were filtered 
off, the filtrate was evaporated and the residue dried in vacuo (10-3 mbar) to give the title complex as a 
colorless solid material (357 mg, 80%); 1H NMR (400 MHz, CD2Cl2): δ = 8.10 (d, J = 7.8 Hz, 1H), 7.75 (d, J = 
7.4 Hz, 1H), [7.69 – 7.6 (m), 7.6 – 7.47 (m); 15H], 7.40 (s, 1H), 7.22 – 7.11 (m, 2H), 1.65 (s, 9H); 13C NMR 
(100 MHz, CD2Cl2): δ = 150.3, 145.5 (br), 141.3, 136.5, 134.7 (d, JPC = 13.8 Hz), 133.1, 131.8 (d, JPC = 2.2 
4
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Hz), 131.1 (d, JPC = 51.6 Hz), 129.6 (d, JPC = 11 Hz), 124.6, 123.5, 121.9, 115.1, 82.8, 28.4;
 31P NMR (162 
MHz CD2Cl2): δ = 45.7; MS (EI): m/z 619 (≤ 1), 459 (4), 432 (6), 320 (34), 276 (21), 262 (100), 232 (20), 183 
(65), 108 (28), 57 (43). 
Complex 15. A solution of complex 14 (184 mg, 0.27 mmol) and (Ph3P)AuNTf2 (201 mg, 0.27 mmol) in 
CH2Cl2 (3 mL) was stirred for 1 h. The mixture was filtered through a short plug of 
Celite and the filtrate was evaporated to give the title complex as a colorless solid 
material (357 mg, 93%). 1H NMR (400 MHz, CD2Cl2): δ = 8.56 (s, 1H), 8.29 (d, J = 8.2 
Hz, 1H), 7.90 (d, J = 7.7 Hz, 1H), 7.8 – 7.3 (m, 32H), 1.74 (s, 9H); 13C NMR (100 MHz, 
CD2Cl2, 50° C): δ = 153.1 (br), 147.9 (br), 141.9 (br), 136.7 (br), 133.8 (d, JPC = 13.8 
Hz), 132.1 (d, JPC = 2.3 Hz), 129.4 (d, JPC = 11.6 Hz), 128.0 (d, JPC = 58.5 Hz), 125.8, 124.0, 123.8, 119.5 (q, 
JCF = 320 Hz), 116.3 (t, JPC = 62.3 Hz), 115.8; 
31P NMR (162 MHz CD2Cl2): δ  38.1; MS (ESI): m/z 1134 [M
+ - 
NTf2]; HRMS (ESI): m/z: calcd. for C49H44Au2NO2P2 [M
+ - NTf2]: 1134.2173, found 1134.2182; Crystals 
suitable for X-ray diffraction were grown from CH2Cl2/pentane. 
Preparation of 4-Hydroxy-2-Pyrones 
Representative Procedure for the Preparation of a Cyclization Precursor by Claisen Condensation: tert-
Butyl 2-Hex-3-oxodec-4-ynoate. t-Butyl octanoate (1.0 g, 0.5 mmol) was added 
dropwise to a stirred solution of LDA (0.5 M in THF, 10 mL, 5 mmol) at –78 °C. 
The mixture was stirred at this temperature for 30 min before methyl 2-
octynoate (771 mg, 0.5 mmol) was slowly introduced and stirring continued at 
–78 °C for 2 h. The mixture was poured into aq. sat. NH4Cl (50 mL) and the organic phase extracted with
Et2O (3 x 50 mL), dried (Na2SO4) and concentrated. Flash chromatography of the residue 
(hexanes/EtOAc, 99:1 → 95:5) gave the title compound as a colorless oil (1.34 g, 83%). 1H NMR (400 
MHz, CDCl3, mixture of keto/enol tautomers): δ  0.85-0.93 (m, 6H), 1.23-1.43 (m, 12H), 1.46 & 1.50 (s 
each,  9H), 1.53-1.62 (m, 2H), 1.80-1.93 (m, 1H), 2.22-2.29 (m, 1H), 2.36 (t, J = 7.1, 1H), 2.40 (t, J = 7.1, 
1H), 3.33 (t, J = 7.4 Hz, 0.5H), 12.33 (s, 0.5H); 13C NMR (100 MHz, CDCl3): δ  13.8, 13.9, 14.0, 14.0, 19.0, 
19.4, 22.0, 22.1, 22.5, 22.6, 27.0, 17.3, 27.8, 27.8, 27.9, 28.1, 28.2, 28.9, 29.0, 29.6, 30.9, 31.0, 31.5, 31.6, 
61.9, 75.0, 79.6, 81.6, 81.7, 96.3, 99.2, 109.4, 152.3, 168.2, 172.8, 183.3. IR (film): ~  = 2957, 2929, 2859, 
2214, 1736, 1677, 1633, 1598, 1457, 1369, 1358, 1250, 1150, 1128, 845, 820 cm-1; MS (EI): m/z (%) 322 
(4), 266 (45), 249 (15), 238 (5), 223 (23), 210 (13), 195 (23), 177 (20), 139 (11), 123 (95), 98 (71), 82 (9), 
67 (23), 57 (100), 41 (38); HRMS (EI): m/z: calcd for C20H34O3Na [M+Na
]: 345.24001, found: 345.23988. 
Representative Procedure for the Preparation of 4-Hydroxy-2-pyrones. Synthesis of Pseudopyronine 
A. A solution of tert-butyl 2-hex-3-oxodec-4-ynoate (325 mg, 1.0 mmol) and 
[SPhosAuNTf2] (9 mg, 10 µmol, 1 mol%) in HOAc (5 mL) was stirred for 24 h 
before the acid was distilled off and the residue purified by flash 
chromatography (hexane/HOAc, 4:1) to afford pseudopyronine A as a white 
solid (257 mg, 96%). Mp = 111.5-112.5 °C (lit. 106-108 °C).6 1H NMR (400 MHz, 
CDCl3): δ  0.86-0.93 (m, 6H), 1.24-1.38 (m, 10H), 1.44-1.54 (m, 2H), 1.58-1.68 (m, 2H), 2.40-2.48 (m, 
6 A. C. Giddens, L. Nielsen, H. I. Boshoff, D. Tasdemir, R. Perozzo, M. Kaiser, F. Wang, J. C. Sacchettini, B. R. 
Copp, Tetrahedron 2008, 64, 1242‒1249.
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4H), 6.20 (s, 1H), 10.19 (br s, 1H); 13C NMR (100 MHz, CDCl3): δ  13.9, 14.1, 22.3, 22.7, 23.1, 26.5, 28.0, 
29.3, 31.1, 31.8, 33.5, 100.9, 103.4, 163.6, 167.2, 168.4; 1H NMR (400 MHz, CD3OD): δ  0.89 (t, J = 7.0 
Hz, 3H), 0.92 (t, J = 7.0 Hz, 3H), 1.32-1.40 (m, 10H), 1.40-1.50 (m, 2H), 1.60-1.70 (m, 2H), 2.37 (t, J = 7.5 
Hz, 2H), 2.46 (t, J = 7.6 Hz, 2H), 4.89 (br s, 1H), 5.98 (s, 1H); 13C NMR (100 MHz, CD3OD): δ  14.2, 14.4, 
23.4, 23.7, 23.9, 27.6, 29.0, 30.2, 32.2, 32.9, 34.2, 101.0, 103.9, 165.1, 167.7, 168.8; IR (film): ~  = 2955, 
2926, 2872. 2858, 2643, 1663, 1630, 1556, 1433, 1407, 1292, 1256, 1172, 1130, 992, 856, 758 cm-1; MS 
(EI): m/z (%) 266 (17), 249 (3), 237 (3), 223 (11), 209 (14), 195 (100), 182 (9), 168 (19), 153 (10), 140 (15), 
126 (11), 111 (7), 99 (11), 83 (4), 69 (10), 55 (21), 43 (21); HRMS (ESI–): m/z: calcd for C16H25O3 [M-H]
–: 
265.18092, found: 265.18085. 
Figure S1. Analysis of the 1H NMR data of two representative products formed by gold catalyzed 6-
endo-dig cyclization; the comparison with the known data for the corresponding tetronic acids (5-exo 
products) corroborates the structure assignment. 
Prepared analogously as colorless crystals (655 mg, 94%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. Mp  106–
107 °C (lit:7a 83 °C); 1H NMR (400 MHz, CDCl3): δ  11.33 (br s, 1H), 6.02 (dt, J  2.0, 1.0 Hz, 
1H), 5.59 (d, J  2.0 Hz, 1H), 2.52 (q, J  7.5 Hz, 2H), 1.20 (t, J  7.5 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
 172.9 (C), 168.5 (C), 168.3 (C), 100.6 (CH), 89.7 (CH), 26.8 (CH2), 10.8 (CH3); IR (film): 
~  = 2984, 2950, 
2566, 1650, 1614, 1574, 1543, 1446, 1383, 1366, 1311, 1283, 1266, 1242, 1203, 1139, 937, 883, 835, 
808, 782, 693, 661 cm1; MS (EI): m/z (%): 140 (37) [M], 111 (70), 99 (16), 69 (100), 57 (26), 29 (24); 
HRMS (EI): m/z: calcd for C7H8O3 [M
]: 140.0473, found: 140.0472. The spectroscopic data are in good 
agreement with the data reported in the literature.7 
Prepared analogously as a white solid (14.9 mg, 97%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. 1H NMR 
(400 MHz, [D6]-DMSO): δ  11.08 (br s, 1H), 5.96 (br s, 1H), 2.43 (q, J  7.5 Hz, 2H), 1.74 (s, 
7
a) D. Schmidt, J. Conrad, I. Klaiber, U. Beifuss Chem. Commun. 2006, 4732‒4734; b) X. Zhang, M. 
McLaughlin, R. L. P. Muñoz, R. P. Hsung, J. Wang, J. Swidorski, Synthesis 2007, 749–753. 
S8 
3H), 1.09 (t, J  7.5 Hz, 3H); 13C NMR (100 MHz, [D6]-DMSO): δ  165.0 (C), 164.9 (C), 163.8 (C), 98.2 (CH), 
96.5 (C), 25.9 (CH2), 10.9 (CH3), 8.3 (CH3); IR (film): 
~  = 2984, 2967, 2914, 2690, 1671, 1634, 1574, 1508, 
1428, 1399, 1373, 1353, 1315, 1238, 1180, 1122, 1088, 1056, 1020, 947, 930, 845, 831, 752, 743, 667 
cm1; MS (EI): m/z (%): 154 (88) [M], 126 (79), 111 (100), 99 (59), 83 (14), 69 (94); HRMS (EI): m/z: calcd 
for C8H10O3 [M
]: 154.0630, found: 154.0631. 
Prepared analogously as a white solid (18.7 mg, 99%); after washing with Et2O, the material 
was found analytically pure, thus requiring no flash chromatography. 1H NMR (400 MHz, 
[D6]-DMSO): δ  11.85 (br s, 1H), 7.84 (m, 2H), 7.51 (m, 3H), 6.75 (d, J  1.9 Hz, 1H), 5.40 (d, 
J  1.9 Hz, 1H); 13C NMR (100 MHz, [D6]-DMSO): δ  170.5 (C), 163.0 (C), 160.1 (C), 131.1 (C), 130.9 (CH), 
129.1 (2  CH), 125.5 (2  CH), 98.4 (CH), 89.6 (CH). The analytical data matched those reported in the 
literature.7a,8 
Prepared analogously as a white solid (18.6 mg, 82%); after washing with Et2O, the 
material was found analytically pure, thus requiring no flash chromatography. Mp = 187-
195 °C (decomp.); 1H NMR (400 MHz, [D6]-DMSO): δ  1.11 (t, J = 7.5 Hz, 3H), 2.48 (dq, J = 
7.5, 0.8 Hz, 2H), 6.08 (t, J = 0.8 Hz, 1H), 12.53 (br s, 1H); 13C NMR (100 MHz, [D6]-DMSO): δ  10.7, 25.7, 
84.9, 98.2, 160.4, 165.8, 166.7; IR (film): ~  = 3082, 1656, 1565, 1428, 1411, 1380, 1326, 1222, 1157, 
1048, 971, 943, 844, 791, 773, 741, 683758 cm-1; MS (EI): m/z (%) 220 (96), 218 (97), 192 (53), 190 (57), 
177 (15), 175 (16), 163 (21), 161 (22), 135 (36), 133 (35), 122 (12), 120 (11), 111 (8), 99 (100), 83 (11), 69 
(25), 57 (30), 53 (29), 39 (12), 29 (27); HRMS (EI): m/z: calcd for C7H6O3Br [M+Na
]: 216.95059, found: 
216.95071. 
Prepared analogously as a white solid (17.5 mg, 85%); after washing with Et2O, the material 
was found analytically pure, thus requiring no flash chromatography. 1H NMR (400 MHz, 
[D6]-DMSO): δ  12.38 (br s, 1H), 7.78 (m, 2H), 7.51 (m, 3H), 6.83 (d, J  5.3 Hz, 1H); 
13C 
NMR (100 MHz, [D6]-DMSO): δ  157.1 (d, JCF  23.7 Hz, C), 154.9 (d, JCF  6.0 Hz, C), 153.8 (d, JCF  9.2 Hz, 
C), 133.0 (C), 130.7 (CH), 130.4 (C), 129.1 (2  CH), 125.3 (2  CH), 98.9 (CH), IR (film): ~  = 2885, 2641, 
2587, 2551, 1625, 1577, 1549, 1495, 1453, 1399, 1356, 1174, 1071, 1048, 910, 859, 824, 770, 734, 685, 
658 cm1; MS (EI): m/z (%): 206 (100) [M], 178 (27), 149 (21), 130 (18), 105 (42), 77 (53), 51 (27); HRMS 
(ESI): m/z: calcd for C11H7O3FNa [M
  Na]: 229.0271, found: 229.0274. 
Prepared analogously as a white solid (8.3 mg, 45%). Mp = 116-118 °C; 1H NMR (400 MHz, 
CDCl3): δ  0.27 (s, 9H), 5.66 (d, J = 2.3 Hz, 1H), 6.36 (d, J = 2.3 Hz, 1H), 11.00 (br s, 1H); 
13C 
NMR (100 MHz, CDCl3): δ  –2.9, 92.5, 112.1, 169.7, 170.1, 175.1; IR (film): 
~  = 3133, 
2961, 1681, 1650, 1631, 1571, 1421, 1283, 1243, 1222, 1188, 1088, 988, 921, 869, 839, 826, 702 cm1; 
MS (EI): m/z (%) 184 (22), 169 (81), 156 (2), 143 (10), 127 (6), 111 (6), 99 (20), 83 (8), 73 (100), 69 (21), 
66 (3), 55 (4), 45 (16), 29 (3); HRMS (EI): m/z: calcd for C8H12O3Si [M+Na
]: 184.05558, found: 184.05542. 
Prepared analogously as a yellow oil (mixture of diastereoisomers, 69 mg, 83%). 
[α]D
20: ‒9.4 (c = 1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 10.09 (bs, 1H), 5.90 (d, J =
1.8 Hz, 1H), 5.41 (d, J = 1.8 Hz, 1H), 4.57 – 4.50 (m, 1H), 3.88 – 3.77 (m, 1H), 3.75 – 
3.65 (m, 1H), 3.51 – 3.43 (m, 1H), 3.39 – 3.13 (m, 1H), 2.60 – 2.50 (m, 1H), 1.83 – 
1.43 (m, 10H), 1.20 (d, J = 7.1 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 170.2, 170.7, 167.8, 100.3, 99.32, 
99.31, 90.0, 67.50, 67.45, 62.78, 62.75, 38.4, 38.3, 31.14, 31.09, 30.8, 27.5, 27.4, 25.5, 19.8, 18.4; IR 
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(film): ?̃? = 2941, 2870, 1665, 1567, 1439, 1367, 1258, 1057, 1022 cm-1. HRMS (ESI): m/z: calcd. for 
C15H22O5Na [M
++Na]: 305.13600, found 305.13594. 
The Trimethylsilylethyl 3-Oxoalkanoate Series 
2-(Trimethylsilyl)ethyl acetate.9 2-Trimethylsilyl-ethanol (7.5 mL, 52.33 mmol) was added dropwise to a 
solution of Mg(ClO4)2 (117 mg, 0.52 mmol) in Ac2O (5.0 mL, 52.90 mmol) and the 
resulting mixture was stirred for 4 h. The reaction was quenched with sat. aq. NaHCO3 
and the aqueous layer extracted with tert-butyl methyl ether. The combined extracts 
were washed twice with sat. aq. NaHCO3, dried over MgSO4, and evaporated to give the title compound 
as a colorless liquid which was pure enough for further use (7.67 g, 91%). 1H NMR (400 MHz, CDCl3): δ = 
4.20 – 4.10 (m, 2H), 2.03 (s, 3H), 1.01 – 0.95 (m, 2H), 0.04 (s, 9H). 13C NMR (101 MHz, CDCl3): δ = 171.5, 
62.8, 21.4, 17.4, ‒1.4. IR (film): ?̃? = 2254, 1730, 1251, 903 cm-1. HRMS (ESI): m/z: calcd. for C7H16O2SiNa
+: 
183.08127; found: 183.08118. 
2-(Trimethylsilyl)ethyl propionate. Prepared analogously from propionic anhydride (5.0 mL, 39.07 
mmol) as a colorless liquid (5.32 g, 78%). 1H NMR (400 MHz, CDCl3): δ = 4.19 – 4.12 
(m, 2H), 2.29 (q, J = 7.6 Hz, 2H), 1.12 (t, J = 7.6 Hz, 3H), 1.00 – 0.94 (m, 2H), 0.00 (s, 
9H). 13C NMR (101 MHz, CDCl3): δ = 174.8, 62.6, 27.9, 17.4, 9.3, ‒1.4. IR (film): ?̃? = 2254, 1725, 1251, 
1180, 903 cm-1. HRMS (ESI): m/z: calcd. for C8H18O2SiNa
+: 197.09690; found: 197.09683. 
2-(Trimethylsilyl)ethyl 2-methyl-3-oxohex-4-ynoate. nBuLi (1.6 M in hexanes, 3.6 mL, 5.76 mmol) was 
added dropwise to a solution of iPr2NH (1.0 mL, 7.14 mmol) in THF (11.5 mL) at 
0 °C. The mixture was stirred for 15 min at 0 °C before it was cooled to ‒78 °C. 
2-(Trimethylsilyl)ethyl propionate (1.0 g, 5.74 mmol) was added dropwise and 
stirring continued at 78°C for 30 min before ethyl-2-butynoate (0.5 mL, 4.23 mmol) was slowly added. 
After stirring at this temperature for 3 h, the reaction was quenched with sat. aq. NH4Cl and the 
aqueous layer extracted with tert-butyl methyl ether. The extracts were washed with brine and dried 
over MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of the 
residue by flash chromatography (hexanes/EtOAc, 20:1) gave the title compound as a colorless liquid 
(942 mg, 91%). 1H NMR (400 MHz, CDCl3, mixture of keto/enol tautomers): δ = 12.18 (s, 0.8 H, enol); 
4.32 – 4.20 (m, 2H, ketone+enol); 3.52 (q, J = 7.2 Hz, 0.2H, ketone); 2.08 (s, 2.4 H, enol); 2.04 (s, 0.5 H, 
ketone); 1.87 (s, 2.4 H, enol); 1.41 (d, J = 7.1 Hz, 0.5 H, ketone); 1.09 – 0.96 (m, 2H, ketone+enol); 0.05 (s, 
7H, enol); 0.04 (s, 1.8H, ketone). 13C NMR (101 MHz, CDCl3, mixture of keto/enol tautomers): δ = 183.3 
(ketone), 173.5 (enol), 170.0 (ketone), 152.3 (enol), 103.3 (enol), 95.9 (enol), 92.9 (ketone), 78.9 
(ketone), 74.3 (enol), 64.0 (ketone), 63.3 (enol), 55.0 (ketone), 17.41 (enol), 17.35 (ketone), 13.1 (enol), 
13.0 (ketone), 4.7 (enol), 4.4 (ketone), ‒1.36 (enol), ‒1.41 (ketone). IR (film): ?̃? = 2254, 1638, 1603, 1392, 
1335, 1253, 1161, 1120, 903 cm-1. HRMS (ESI): m/z: calcd. for C12H20O3SiNa
+: 263.10742; found: 
263.10739. 
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2-(Trimethylsilyl)ethyl 2-methyl-3-oxo-5-phenylpent-4-ynoate. Prepared analogously as a colorless 
liquid (627 mg, 96%). 1H NMR (400 MHz, CDCl3, mixture of keto/enol 
tautomers): δ = 13.47 (s, 0.9 H, enol); 7.64 – 7.46 (m, 2H, ketone+enol); 7.46 – 
7.27 (m, 3H, ketone+enol); 4.35 -4.24 (m, 2H, ketone+enol); 3.66 (q, J = 7.3 
Hz, 0.1H, ketone); 2.00 (s, 2.7 H, enol); 1.50 (d, J = 7.3 Hz, 0.3H, ketone); 1.11 – 1.03 (m, 2H, 
ketone+enol); 0.07 (s, 8H, enol); 0.02 (s, 1H, ketone). 13C NMR (101 MHz, CDCl3, enol form): δ = 173.3, 
152.0, 132.1, 129.8, 128.6, 121.4, 104.5, 97.8, 83.1, 63.5, 17.5, 13.4, ‒1.3. IR (film): ?̃? = 2954, 2215, 1738, 
1638, 1605, 1591, 1390, 1336, 1278, 1190, 1060 cm-1. HRMS (ESI): m/z: calcd. for C17H22O3SiNa
+: 
325.123010; found: 325.123043. 
(2R,3S,4R)-3,4-bis(Benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carbaldehyde (S-1).10 
POCl3 (2.45 mL, 26.16 mmol) was added dropwise over 1 h to a solution of tri-O-
benzyl-D-glucal (1.00 g, 2.4 mmol) in DMF (4 mL) at 0°C. The mixture was stirred for 
24 h while slowly warming to room temperature. The reaction was quenched with 
sat. aq. NaHCO3 and the aqueous layer was extracted with tert-butyl methyl ether. 
The combined extracts were washed with brine and dried over MgSO4, the drying agent was filtered off 
and the solvent was evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 
5:1) afforded the title compound (807 mg, 76%). [α]D
20: +2.1 (c = 1, CHCl3; Lit.:
10 [α]D
25: +6.8, c = 0.34,
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 9.41 (s, 1H), 7.42 – 7.20 (m, 15H), 4.77 – 4.71 (m, 1H), 4.71 – 4.44 
(m, 7H), 4.42 (t, J = 2.3 Hz, 1H), 3.84 (t, J = 2.3 Hz, 1H), 3.80 (dd, J = 10.9, 7.8 Hz, 1H), 3.63 (dd, 10.7, 4.7 
Hz, 1H). 13C NMR (101 MHz, CDCl3): δ = 190.5, 164.4, 138.3, 137.8, 137.3, 128.7, 128.6, 128.5, 128.2, 
128.0, 127.93, 127.87, 127.8, 117.9, 79.5, 73.5, 72.6, 71.8, 71.5, 68.5, 65.4. IR (film): ?̃? = 3064, 3031, 
2866, 1673, 1626, 1454, 1294, 1199, 1089, 1072 cm-1. HRMS (ESI): m/z: calcd. for 
C28H28O5Na
+: 467.18306; found: 467.18289. 
(2R,3S,4R)-3,4-bis(Benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylic acid (S-2). 
NaH2PO4 (5.60 g, 46.68 mmol) and H2O2 (7.5 mL, 77.17 mmol, 35% in H2O) were 
added to a solution of S-1 (6.45 g, 15.49 mmol) in CH3CN/tBuOH/H2O (2:2:1, 70 mL) 
at 0°C. The mixture was stirred for 5 min before NaClO2 (8.4 g, 92.88 mmol) was 
added. Stirring was then continued for 16 h at room temperature before the mixture 
was diluted with water and the aqueous phase was extracted with tert-butyl methyl ether. The 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and 
the solvent was evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 5:1) 
afforded the title compound (5.60 g, 79%). [α]D
20: ‒4.2 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.79
(s, 1H), 7.39 – 7.21 (m, 15H), 4.72 – 4.63 (m, 2H), 4.59 – 4.49 (m, 4H), 4.44 (d, J = 12.1 Hz, 1H), 4.34 (t, J = 
2.3 Hz, 1H), 3.82 (t, J = 2.2 Hz, 1H), 3.78 (dd, J = 10.7, 7.7 Hz, 1H), 3.62 (dd, J = 10.7, 4.9 Hz, 1H). 13C NMR 
(101 MHz, CDCl3): δ = 172.9, 157.6, 138.3, 137.8, 137.5, 128.7, 128.6, 128.5, 128.15, 128.11, 127.91, 
127.88, 127.85, 127.1, 104.7, 77.5, 73.5, 72.4, 71.6, 71.4, 68.4, 67.8. IR (film): ?̃? = 3063, 3030, 2863, 
1647, 1453, 1362, 1238, 1097, 1069, 1047, 1027 cm-1. HRMS (ESI): m/z: calcd. for 
C28H28O6Na
+: 483.17805; found: 483.17781.  
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2-(Trimethylsilyl)ethyl (2R,3S,4R)-3,4-bis(benzyloxy)-2-((benzyloxy)methyl)-3,4-dihydro-2H-pyran-5-
carboxylate (S-3). DEAD (6.70 mL, 36.77 mmol) was added dropwise over 60 min to a 
solution of compound S-2 (5.60 g, 12.15 mmol), 2-(TMS)-ethanol (4.5 mL, 
31.39 mmol) and PPh3 (11.50 g, 43.84 mmol) in THF (60 mL) at 0°C. After stirring for 
16 h at room temperature, the reaction was quenched with sat. aq. NH4Cl and the 
aqueous phase extracted with tert-butyl methyl ether. The combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 10:1) afforded the 
title compound (5.25 g, 77%). [α]D
20: ‒15.8 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.65 (s, 1H), 7.39
– 7.20 (m, 15H), 4.65 (d, J = 11.4 Hz, 1H), 4.64 – 4.59 (m, 1H), 4.58 – 4.47 (m, 4H), 4.43 (d, J = 11.9 Hz,
1H), 4.35 (t, J = 2.1 Hz, 1H), 4.29 – 4.21 (m, 2H), 3.80 (t, J = 2.3 Hz, 1H), 3.76 (dd, J = 10.6, 7.6 Hz, 1H), 
3.61 (dd, J = 10.7, 4.9 Hz, 1H), 1.06 – 0.98 (m, 2H), 0.06 (s, 9H). 13C NMR (101 MHz, CDCl3): δ = 167.5, 
155.3, 138.4, 137.9, 137.6, 128.7, 128.6, 128.5, 128.12, 128.10, 127.92, 127.86, 127.8, 105.7, 77.1, 73.5, 
72.5, 71.61, 71.56, 68.4, 68.1, 62.5, 17.6, 1.3. IR (film): ?̃? = 3031, 2952, 2897, 1701, 1633, 1454, 1293, 
1275, 1250, 1195, 1071, 1028 cm-1. HRMS (ESI): m/z: calcd. for C33H40O6SiNa
+: 583.24854; 
found: 583.24864.  
2-(Trimethylsilyl)ethyl (2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)-
oxy)methyl)-3,4-dihydro-2H-pyran-5-carboxylate (S-4). Pd(OH)2/C (375 mg, 10% 
w/w) was added to a solution of compound S-3 (3.75 g, 6.69 mmol) in 
CH3OH (66 mL). The solution was purged with H2 and stirred for 15 h under a H2 
atmosphere (1 atm). The mixture was then filtered through a plug of Celite® and 
the filtrate was concentrated.  
TBSOTf (6.20 mL, 26.99 mmol) was added to a solution of the crude triol in CH2Cl2 (16.5 mL) and 
pyridine (6.5 mL) at 0 °C. The mixture was stirred for 16 h while warming to room temperature, before 
the reaction was quenched with sat. aq. NH4Cl and the aqueous phase extracted with tert-butyl methyl 
ether. The combined extracts were washed with brine and dried over MgSO4. The drying agent was 
filtered off and the solvent evaporated. Purification of the residue by flash 
chromatography (hexanes/EtOAc, 60:1) furnished the title compound (3.72 g, 88%). [α]D
20: +4.3 (c = 1,
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.55 (s, 1H), 4.36 – 4.20 (m, 3H), 4.20 – 4.08 (m, 1H), 3.93 (dd, J = 
11.6, 8.1 Hz, 1H), 3.90 – 3.85 (m, 1H), 3.73 (dd, J = 11.7, 3.9 Hz, 1H), 1.07 – 0.97 (m, 2H), 0.89 (s, 9H), 
0.84 (s, 18H), 0.15 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.05 (s, 3H), 0.04 (s, 12H). 13C NMR 
(101 MHz, CDCl3): δ = 167.7, 154.4, 106.7, 82.3, 68.3, 63.8, 62.3, 62.1, 26.1, 25.84, 25.78, 18.5, 18.13, 
18.10, 17.5, 1.3, 4.6, 4.67 (2 C), 4.71, 5.05, 5.14. IR (film): ?̃? = 2954, 2930, 2896, 2858, 1706, 




oxy)methyl)-6-iodo-3,4-dihydro-2H-pyran-5-carboxylate (S-5). nBuLi (1.6 M in hexanes, 1.60 mL, 
2.56 mmol) was added dropwise to a solution of iPr2NH (0.50 mL, 3.57 mmol) in 
THF (5.70 mL) at 0°C and the resulting mixture was stirred for 15 min before it was 
cooled to ‒78°C. A solution of compound S-4 (540 mg, 0.85 mmol) in THF (5.70 mL) 
was added dropwise and the resulting mixture was stirred for 1.5 h. A solution of 
iodine (1.08 g, 4.26 mmol) in THF (5.70 mL) was then added dropwise and stirring 
S12 
was continued for 30 min. The reaction was quenched with sat. aq. Na2S2O3 and the aqueous layer 
extracted with tert-butyl methyl ether. The combined extracts were washed with brine and dried over 
MgSO4, the drying agent was filtered off and the solvent was evaporated. Purification of the residue by 
flash chromatography (hexanes/EtOAc, 20:1) afforded the title compound (598 mg, 92%). [α]D
20: +4.2 (c
= 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.45 (t, J = 2.4 Hz, 1H), 4.41 – 4.32 (m, 1H), 4.32 – 4.26 (m, 
1H), 4.15 – 4.06 (m, 1H), 4.02 – 3.94 (m, 2H), 3.79 (dd, J = 11.5, 4.9 Hz, 1H), 1.06 (dd, J = 9.6, 8.1 Hz, 2H), 
0.89 (s, 9H), 0.85 (s, 9H), 0.83 (s, 9H), 0.11 (s, 3H), 0.08 (s, 9H), 0.06 – 0.02 (m, 15H). 13C NMR (101 MHz, 
CDCl3): δ = 166.7, 119.6, 112.7, 87.1, 67.9, 66.5, 63.0, 61.7, 26.1, 25.78, 25.76, 18.5, 18.10, 18.07, 17.6, 
1.4, 4.4, 4.5, 4.6, 4.8, 5.0, 5.2. IR (film): ?̃? = 2953, 2929, 2894, 2857, 1698, 1584, 1471, 1521, 
1113, 1064 cm-1. HRMS (ESI): m/z: calcd. for C30H63O6Si4INa
+: 781.26417; found: 781.26387. 
2-(Trimethylsilyl)ethyl (2R,3R,4R)-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)-
oxy)methyl)-6-(hex-1-yn-1-yl)-3,4-dihydro-2H-pyran-5-carboxylate. 1-Hexyne (0.1 mL, 0.87 mmol) was 
added to a degassed solution of S-5 (100 mg, 0.13 mmol) and NEt3 (2.5 mL, 
17.94 mmol) in THF (0.9 mL) at room temperature, followed by CuI (5 mg, 
0.03 mmol, 20 mol%) and Pd(PPh3)2Cl2 (10 mg, 0.01 mmol, 10 mol%). The 
mixture was stirred for 15 h before it was filtered through a plug of Celite®. 
The filtrate was diluted with sat. aq. NH4Cl and the aqueous phase extracted 
with tert-butyl methyl ether. The combined extracts were washed with brine and dried over MgSO4, the 
drying agent was filtered off and the solvent was evaporated. Purification of the residue by flash 
chromatography (hexanes/EtOAc, 60:1) afforded the title compound as a colorless syrup (88 mg, 93%). 
[α]D
20: +2.3 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.46 (t, J = 2.4 Hz, 1H), 4.41 – 4.30 (m, 1H), 4.29
– 4.21 (m, 1H), 4.19 – 4.08 (m, 1H), 3.94 (dd, J = 2.8, 1.5 Hz, 1H), 3.90 (dd, J = 11.4, 7.6 Hz, 1H), 3.80 ( dd,
J = 11.3, 5.4 Hz, 1H), 2.42 (t, J = 7.1 Hz, 2H), 1.64 – 1.54 (m, 2H), 1.50 – 1.39 (m, 2H), 1.10 – 1.00 (m, 2H), 
0.92 (t, J = 7.3 Hz, 3H), 0.89 (s, 9H), 0.86 (s, 9H), 0.83 (s, 9H), 0.14 (s, 3H), 0.09 – 0.06 (m, 12H), 0.06 – 
0.03 (m, 12H). 13C NMR (101 MHz, CDCl3): δ = 167.3, 144.2, 109.9, 96.9, 82.5, 75.9, 67.7, 65.6, 62.4, 62.0, 
30.3, 26.1, 25.9, 25.8, 22.3, 19.5, 18.5, 18.2, 17.7, 13.8, 1.4, 4.46, 4.53, 4.6, 4.7, 5.0, 5.2. IR 
(film): ?̃? = 2954, 2930, 2858, 1689, 1602, 1471, 1389, 1251, 1112, 1069 cm-1. HRMS (ESI): m/z: calcd. for 
C36H72O6Si4Na
+: 735.42997; found: 735.42982.  
2-(Trimethylsilyl)ethyl (2R,3S,4R)-6-(3-acetoxyprop-1-yn-1-yl)-3,4-bis(benzyloxy)-2-((benzyloxy)-
methyl)-3,4-dihydro-2H-pyran-5-carboxylate. Prepared analogously from 
propargyl acetate (33 µL, 0.33 mmol) and S-5 (50 mg, 0.07 mmol) (42 mg, 
87%). [α]D
20: +3.5 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.88 (s, 2H),
4.44 (t, J = 2.3 Hz, 1H), 4.39 – 4.30 (m, 1H), 4.29 – 4.23 m, 1H), 4.19 – 4.09 (m, 
1H), 3.94 (dd, J = 2.8, 1.5 Hz, 1H), 3.88 (dd, J = 11.4, 7.6 Hz, 1H), 3.79 (dd, J = 
11.4, 5.6 Hz, 1H), 2.10 (s, 3H), 1.09 – 1.01 (m, 2H), 0.88 (s, 9H), 0.85 (s, 9H), 
0.83 (s, 9H), 0.13 (s, 3H), 0.08 – 0.07 (m, 6H), 0.07 – 0.05 (m, 6H), 0.04 (s, 9H), 0.03 (s, 3H). 13C NMR (101 
MHz, CDCl3): δ = 170.3, 166.7, 143.0, 111.6, 88.3, 82.7, 81.3, 67.5, 65.3, 62.8, 61.8, 52.6, 26.1, 25.82, 
25.76, 20.9, 18.5, 18.1, 17.4, 1.4, 4.5, 4.58, 4.62, 4.8, 5.1, 5.2. IR (film): ?̃? = 2953, 2929, 2857, 
1753, 1692, 1607, 1472, 1389, 1321, 1250, 1217, 1111, 1067 cm-1. HRMS (ESI): m/z: calcd. for 
C35H68O8Si4Na




oxy)methyl)-6-(3-hydroxyprop-1-yn-1-yl)-3,4-dihydro-2H-pyran-5-carboxylate. Prepared analogously 
from S-5 (147 mg, 0.19 mmol) and propargylic alcohol (36 µL, 0.62 mmol) (116 
mg, 87%). [α]D
20: +6.9 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 4.50 – 4.45 
(m, 2H), 4.45 (t, J = 2.4 Hz, 1H), 4.40 – 4.31 (m, 1H), 4.29 – 4.22 (m, 1H), 4.16 – 
4.07 (m, 1H), 3.95 (dd, J = 2.6, 1.4 Hz, 1H), 3.88 (dd, J = 11.2, 7.4 Hz, 1H), 3.80 
(dd, J = 11.4, 5.5 Hz, 1H), 2.26 (bs, 1H), 1.04 (dd, J = 9.5, 7.9 Hz, 1H), 0.88 (s, 
9H), 0.85 (s, 9H), 0.83 (s, 9H), 0.13 (s, 3H), 0.08 (s, 6H), 0.06 (s, 6H), 0.04 (s, 
12H). 13C NMR (101 MHz, CDCl3): δ = 166.9, 143.6, 111.1, 93.1, 82.6, 80.6, 67.5, 65.3, 62.8, 61.8, 51.6, 
26.1, 25.81, 25.75, 18.5, 18.1, 17.5, 1.2, 1.4, 4.4, 4.58, 4.63, 4.8, 5.1, 5.2. IR (film): ?̃? = 3429, 
2953, 2930, 2896, 2857, 1692, 1601, 1472, 1389, 1251, 1220, 1070 cm-1. HRMS (ESI): m/z: calcd. for 
C33H66O7Si4Na
+: 709.37782; found: 709.37779. 
 3,6-Dimethyl-4-hydroxy-2-pyrone. SPhosAuNTf2 (4 mg, 0.005 mmol, 1 mol%) was added to a solution 
of 2-(trimethylsilyl)ethyl 2-methyl-3-oxohex-4-ynoate (120 mg, 0.5 mmol) in HOAc (2.5 
mL) and the resulting mixture was stirred for 2 h. The solvent was evaporated and the 
residue washed with Et2O to yield the title compound as a white solids in analytically pure 
form (68 mg, 97%). 1H NMR (400 MHz, CD3OD): δ = 5.99 (s, 1H), 2.20 (s, 3H), 1.84 (s, 3H). 
13C NMR (101 
MHz, CD3OD): δ = 169.1, 167.9, 161.4, 101.5, 98.7, 19.5, 8.2. IR (film): ?̃? = 2958, 2926, 2856, 2672, 1729, 
1638, 1582, 1404, 1251, 1131 cm-1. HRMS (ESI): m/z: calcd. for C7H8O3Na
+: 163.03661; found: 163.03656. 
 3-Methyl-6-phenyl-4-hydroxy-2-pyrone. Prepared analogously as a white solid (126 mg, 94%). 1H NMR 
(400 MHz, [D5]-pyridine): δ = 7.87 – 7.77 (m, 2H), 7.36 – 7.26 (m, 3H), 6.82 (s, 1H), 2.28 (s, 
3H). 13C NMR (101 MHz, [D5]-pyridine): δ = 166.0, 165.4, 157.6, 132.2, 130.5, 129.1, 125.6, 
99.9, 98.7, 9.4. IR (film): ?̃? = 2877, 2650, 2543, 1612, 1560, 1395, 1372, 1260, 1229, 1154 
cm-1. HRMS (ESI): m/z: calcd. for C12H10O3Na
+: 225.05221; found: 225.05224. 
 (2R,3R,4R)-7-Butyl-3,4-bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-3,4-
dihydro-2H,5H-pyrano[4,3-b]pyran-5-one. Prepared analogously using 
CH3NO2 as the solvent (50 mg, 83%). [α]D
20: +34.1 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 5.75 (s, 1H), 4.31-4.12(m, 2H), 4.01 – 3.92 (m, 2H), 3.80 (dd, 
J = 11.6, 4.0 Hz, 1H), 2.44 (t, J = 7.6 Hz, 2H), 1.68 – 1.57 (m, 2H), 1.36 (hex, J = 
7.4 Hz, 2H), 0.92(t, J = 7.3 Hz, 3H), 0.89 (s, 9H), 0.86 (s, 9H), 0.82 (s, 9H), 0.21 (s, 3H), 0.16 (s, 3H), 0.09 (s, 
3H), 0.07 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 165.5, 164.8, 163.4, 99.5, 98.6, 
83.3, 68.4, 63.6, 62.5, 33.5, 28.7, 26.04, 25.94, 25.80, 22.2, 18.5, 18.2, 18.1, 13.9, 4.5, 4.6, 4.7, 4.9, 
5.09, 5.13. IR (film): ?̃? = 2954, 2929, 2857, 1721, 1652, 1588, 1433, 1523, 1105, 1071 cm-1. HRMS 
(ESI): m/z: calcd. for C31H60O6Si3Na
+: 635.35868; found: 635.35899.  
 ((2R,3R,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-5-oxo-3,4-
dihydro-2H,5H-pyrano[4,3-b]pyran-7-yl)methyl acetate. Prepared analogously 
in CH3NO2 as the solvent (18 mg, 91%). [α]D
20: +38.8 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 6.01 (s, 1H), 4.82 (s, 2H), 4.42 – 4.32 (m, 2H), 3.98 (dd, J = 2.5, 
1.8 Hz, 1H), 3.94 (dd, J = 11.6, 8.1 Hz, 1H), 3.82 (dd, J = 11.6, 4.3 Hz, 1H), 2.15 
(s, 3H), 0.89 (s, 9H), 0.86 (s, 9H), 0.83 (s, 9H), 0.21 (s, 3H), 0.16 (s, 3H), 0.09 (s, 3H), 0.07 (s, 3H), 0.04 (s, 
3H), 0.02 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 170.2, 163.5, 162.7, 157.9, 101.0, 100.4, 83.5, 68.2, 
63.5, 62.3, 61.6, 26.0, 25.9, 25.8, 20.8, 18.5, 18.2, 18.1, 4.5, 4.7, 4.8, 4.9, 5.11, 5.14. IR (film): ?̃? = 
S14 
 
2953, 2923, 2857, 1754, 1727, 1662, 1591, 1431, 1252, 1219, 1071 cm-1. HRMS (ESI): m/z: calcd. for 
C30H56O8Si3Na
+: 651.31722; found: 671.31753.  
 (2R,3R,4R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-7-
(hydroxymethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-one. Prepared analogously in CH3NO2 as the 
solvent (100 mg, 89%). [α]D
20: +41.1 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ 
= 6.11 (s, 1H), 4.44 – 4.32 (m, 4H), 4.00 – 3.97 (m, 1H), 3.95 (dd, J = 10.7, 7.2 
Hz, 1H), 3.81 (dd, J = 11.6, 4.3 Hz, 1H), 3.13 (bs, 1H), 0.88 (s, 9H), 0.85 (s, 9H), 
0.81 (s, 9H), 0.19 (s, 3H), 0.14 (s, 3H), 0.08 (s, 3H), 0.06 (s, 3H), 0.04 (s, 3H), 
0.02 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 164.3, 163.5, 163.2, 99.5, 99.2, 83.5, 68.1, 63.4, 62.4, 61.1, 
26.0, 25.8, 25.7, 18.4, 18.2, 18.0, 4.6, 4.7, 4.8, 5.0, 5.1, 5.2. IR (film): ?̃? = 3413, 2953, 2926, 2857, 
1724, 1697, 1587, 1472, 1432, 1254, 1077 cm-1. HRMS (ESI): m/z: calcd. for C28H54O7Si3Na
+: 609.30704; 
found: 609.30696.  
 
Preparation of 2-Alkoxy-4-pyrones. 
2-Ethyl-6-methoxy-4H-pyran-4-one. SPhosAuNTf2 (1.3 mg, 1.5 mol) was added to a solution of methyl 
3-oxohept-4-ynoate (21.8 mg, 0.141 mmol) in HOAc (0.5 mL). The mixture was stirred for 24 h and 
concentrated, and the residue was purified by flash chromatography (hexanes/EtOAc, 
1:1  0/1) to give the title compound as a colorless solid (19.4 mg, 89%). 1H NMR (400 
MHz, CDCl3): δ = 1.20 (t, J = 7.5 Hz, 3H), 2.49 (dq, J = 7.5, 0.7 Hz, 2H), 3.84 (s, 3H), 5.43 (d, 
J = 1.8 Hz, 1H), 5.97 (dt, J = 1.8, 0.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 10.8, 26.3, 56.2, 89.6, 111.1, 
166.4, 168.3, 182.0; IR (film): ~  = 3074, 2972, 2941, 1657, 1611, 1576, 1455, 1393, 1241, 1161, 1054, 
985, 961, 918, 882, 839 cm1; MS (EI): m/z (%) 154 (76), 139 (3), 126 (12), 111 (72), 101 (11), 83 (12), 69 
(100), 59 (12), 39 (15), 33 (1), 29 (21); HRMS (EI): m/z: calcd for C8H10O3 [M
+]: 154.06300, found: 
154.06313. 
3-Bromo-6-ethyl-2-methoxy-4H-pyran-4-one. Prepared analogously as a as a colorless solid (16.9 mg, 
66%). 1H NMR (400 MHz, CDCl3): δ = 1.25 (t, J = 7.5 Hz, 3H), 2.57 (dq, J = 7.5, 0.8 Hz, 2H), 
4.08 (s, 3H), 6.12 (t, J = 0.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 10.8, 25.9, 56.7, 90.3, 
110.5, 162.7, 164.5, 175.6; IR (film): ~  = 2961, 1660, 1633, 1571, 1466, 1420, 1373, 
1347, 1293, 1246, 1146, 1102, 1062, 1024, 977, 913, 847, 727 cm1; MS (EI): m/z (%) 234 
(98), 232 (100), 219 (5), 217 (5), 191 (20), 189 (21), 180 (65), 178 (68), 149 (16), 147 (14), 121 (14), 106 
(5), 93 (15), 81 (18), 69 (46), 59 (55), 53 (39), 43 (17), 39 (40); HRMS (ESI+): m/z: calcd for C8H9BrNaO3 
[M+Na+]: 254.96274, found: 254.96275. 
2-(Benzyloxy)-6-ethyl-2H-pyran-4-one. Prepared analogously as a white solid (21.6 mg, 94%). Mp = 75-
76 °C; 1H NMR (400 MHz, CDCl3): δ  1.21, (t, J = 7.5 Hz, 3H), 2.51 (dt, J = 7.5, 0.5 Hz, 
2H), 5.09 (s, 2H), 5.54 (d, J = 1.8 Hz, 1H), 5.99 (m, J = 1.8 Hz, 1H), 7.35-7.44 (m, 5H); 13C 
NMR (400 MHz, CDCl3): δ  10.7, 26.2, 71.2, 90.9, 111.1, 127.9, 128.9, 129.0, 133.7, 
166.4, 167.1, 181.9; IR (film): ~  = 3051, 2973, 2914, 1656, 1615, 1589, 1575, 1500, 
1455, 1416, 1380, 1366, 1302, 1251, 1226, 103, 1157, 1091, 1059, 1029, 1005, 978, 924, 898, 800, 787, 
740, 691, 681, 670 cm1; MS (EI): m/z (%) 230 (1) 174 (1), 132 (15), 91 (100), 77 (1), 65 (9), 51 (1), 40 (3), 
29 (2) HRMS (EI): m/z: calcd for C14H14O3Na [M+Na





4-one. Prepared analogously in MeCN/HOAc (5:1) as a colorless oil (27.5 
mg, 86%). 
25
D][ = −22.7 (c = 0.65, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 
1.00 (t, J = 7.4 Hz, 3H), 1.49-1.58 (m, 2H), 1.69-1.89 (m, 4H), 1.77 (t, J = 2.5 
Hz, 3H), 1.77 (t, J = 2.5 Hz, 3H), 2.13-2.21 (m, 2H), 2.29-2.46 (m, 2H), 2.48 
(t, J = 7.6 Hz, 2H), 2.76-2.83 (m, 2H), 2.86-2.93 (m, 2H), 3.36 (s, 3H), 3.82 
(dt, J = 6.3, 3.3 Hz, 1H), 4.36 (dt, J = 8.0, 3.8 Hz, 1H), 4.64 (d, J = 6.9 Hz, 
1H), 4.66 (d, J = 6.9 Hz, 1H), 5.33-5.56 (m, 5H), 5.99 (d, J = 1.5 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 3.6, 
3.6, 10.2, 17.3, 18.5, 22.6, 25.8, 25.8, 28.2, 28.7, 32.6, 56.0, 75.7, 76.3, 76.8, 77.4, 78.4, 83.4, 91.6, 96.2, 
112.3, 125.0, 125.8, 128.7, 130.6, 164.9, 167.1, 182.0; IR (film): ~  = 2921, 1661, 1625, 1581, 1398, 1241, 
1149, 1100, 1031, 918, 855, 751 cm1; MS (EI): m/z (%) 454 (3), 409, (1), 383 (2), 352 (2), 321 (4), 263 (2), 
251 (31), 219 (9), 207 (21), 177 (9), 117 (15), 91 (18), 71 (14), 45 (100); HRMS (ESI): m/z: calcd. for 
C28H38NaO5 [M+Na
+]: 477.26114, found: 477.26141. 
2-(Heptyl)-6-[(3S,4R,6Z)-4-(methoxymethoxy)-undecene-2-yl]-4H-pyran-4-one. Prepared analogously in 
MeCN/HOAc (3:1) as a colorless oil (95 mg, 95%). 
20
D][ = 14.3 (c = 0.33, 
CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 5.98 (s, 1H), 5.55-5.35 (m, 3H), 4.64 
(dd, J = 15.6, 6.9 Hz, 2H), 4.37-4.33 (m, 1H), 3.83-3.79 (m, 1H), 3.35 (s, 3H), 
2.45-2-27 (m, 4H), 2.03-1.99 (m, 2H), 1.88-1.57 (m, 4H), 1.43-1.29 (m, 6H), 
0.99 (t, J = 7.4 Hz, 3H), 0.93 (t, J = 7.3 Hz, 3H), 0.88 (t, J = 7.0 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ = 182.5, 174.5, 167.2, 165.5, 133.4, 124.0, 112.0, 
96.1, 91.5, 83.5, 76.8, 55.8, 32.7, 31.7, 28.7, 27.2, 22.4, 22.3, 22.1, 14.0, 
13.7, 10.1; IR (film): ?̃? = 2957, 2929, 1719, 1661, 1579, 1402, 1245, 1090, 920, 855 cm1; MS (ESI+): 
[M+Na+]: 403; HRMS (ESI): m/z: calcd. for C22H36O5[M+Na
+]: 403.24549, found: 403.24553. 
Representative Procedure for the Silver-Catalyzed Preparation of 2-tert-Butoxy-4-pyrones. 2-(tert-
Butoxy)-6-pentyl-4H-pyran-4-one. N,N’-Dimethylethylenediamine (DMEDA, 4.4 
mg, 0.05 mmol, 5 mol%) and AgOTs (14 mg, 0.05 mmol, 5 mol%) were 
successively added to a solution of tert-butyl-3-oxodec-4-ynoate (238.3 mg, 0.5 
mmol) in chloroform (5 mL).11 The mixture was stirred until TLC showed 
complete conversion of the substrate (ca. 24 h). The mixture was filtered through a plug of silica, eluting 
with tert-butyl methyl ether, and the filtrate was evaporated. Flash chromatography (silica) furnished 
the title compound as a colorless oil (203 mg, 85%). 1H NMR (400 MHz, CDCl3):
11 δ = 5.98 (d, 1H, J = 1.9 
Hz), 5.56 (d, 1H, J = 2.0 Hz), 2.45 (t, 2H, J = 7.5 Hz), 1.67-1.59 (m, 2H), 1.48 (s, 9H), 1.35-1.29 (m, 4H), 
0.89 (t, 3H, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3):
11 δ = 182.4, 165.7, 165.5, 112.4, 98.3, 85.3, 33.1, 30.9, 
28.7, 26.3, 22.2, 13.8; IR (film): ?̃? = 2932, 2863, 1657, 1626, 1586, 1370, 1246, 1136, 932, 857, 752 cm-1; 
MS (EI) m/z (%): 238 (3), 183 (15), 182 (34), 154 (3), 140 (11), 127 (7), 126 (100), 122 (6), 112 (4), 111 
(51), 98 (33), 97 (10), 71 (5), 69 (29), 57 (53), 56 (9), 55 (17), 43 (16), 41 (45), 39 (16), 29 (17), 27 (8); 
HRMS (ESI): m/z: calcd. for C14H22O3Na [M
++Na]: 261.14611, found 261.14613. 
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Prepared analogously as a colorless oil (142 mg, 88%). 1H NMR (400 MHz, CDCl3): 
δ = 5.99 (s, 1H), 2.43 (t, 2H, J = 7.5 Hz), 2.30 (t, 2H, J = 7.4 Hz), 1.66-1.55 (m, 2H), 
1.47 (s, 9H), 1.45-1.37 (m, 2H), 1.35-1.20 (m, 10H), 0.88 (t, 3H, J = 6.9 Hz), 0.85 (t, 
3H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3): δ = 181.6, 163.6, 162.6, 112.0, 110.7, 
84.4, 32.9, 31.6, 30.8, 29.2, 28.1, 26.3, 22.6, 22.4, 22.2, 14.0, 13.8; IR (film): ?̃? = 
2956, 2927, 2858, 1660, 1627, 1589, 1400, 1370, 1263, 1144, 836, 741, 710 cm-1; MS (EI) m/z (%): 322 
(6), 267 (17), 266 (31), 265 (8), 249 (5), 237 (5), 224 (20), 223 (22), 210 (11), 209 (20), 197 (12), 195 
(100), 168 (26), 167 (7), 153 (9), 141 (8), 140 (12), 126 (9), 111 (4), 99 (10), 71 (4), 57 (51), 55 (6), 43 (10), 
41 (14), 29 (5); HRMS (ESI): m/z: calcd. for C20H34O3Na [M
++Na]: 345.24001, found 345.24029. 
Prepared analogously as a white solid (106 mg, 87 %). Mp = 63-64 °C. 1H NMR (300 
MHz, CDCl3): δ = 7.71-7.67 (m, 2H), 7.47-7.42 (m, 3H), 6.62 (d, 1H, J = 1.9 Hz), 5.68 (d, 
1H, J = 2.0 Hz), 1.53 (s, 9H); 13C NMR (75 MHz, CDCl3): δ = 182.1, 165.3, 160.8, 131.1, 
131.0, 129.0, 125.7, 110.4, 99.3, 85.6, 28.7; IR (film): ?̃? = 3069, 2978, 2932, 1649, 
1587, 1449, 1371, 1334, 1229, 1138, 939, 876, 837, 766, 682, 633, 510, 450 cm-1; MS 
(EI) m/z (%): 244 (5), 188 (51), 161 (11), 160 (100), 147 (8), 131 (11), 105 (41), 104 (6), 103 (7), 77 (28), 




Hispidine and Phellinin A 
Compound 20. Et3N (70 µL, 0.95 mmol, 5 mol%) was added to a stirred suspension of 3,4-
(methylenedioxy)cinnamic acid (1.92 g, 10 mmol) in CH3CN/H2O (9:1, 30mL), followed 
by portionwise addition of NBS (2.1 g, 12 mmol). The mixture was stirred for 15 min 
(after a few minutes, all starting material had dissolved). For work up, the mixture was 
poured into water (100 mL), the aqueous layer was repeatedly extracted with Et2O, and the combined 
extracts were dried (Na2SO4) and concentrated. Purification of the residue by flash chromatography 
(hexanes/CH2Cl2, 3:1) gave the title compound in the form of white crystals. (2.07 g, 91 %). 
1H NMR (400 
MHz, CDCl3): δ = 5.96 (s, 2H), 6.59 (d, J = 13.9 Hz, 1H), 6.75 (d, J = 2.4 Hz, 1H), 6.75 (s, 1H), 6.81 (d, J = 0.8 
Hz, 1H), 7.0 (d, J = 13.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ = 101.3, 104, 5, 105.4, 108.4, 120.9, 130.3, 
136.7, 147.8, 148.1. 
Compound 21. Ethyl propiolate (253 µL, 2.5 mmol) was added dropwise to a stirred solution of LDA (0.5 
M in THF, 5 mL, 2.5 mmol,) at 78 °C. The mixture was stirred at this 
temperature for 30 min before a solution of ZnBr2 (1 M in THF, 2.5 mL, 2.5 
mmol) was introduced. The mixture was warmed to 0°C and stirring continued 
for 15 min. Compound 20 (228 mg, 1.0 mmol) and Pd(PPh3)4 (62 mg, 53 µmol, 5 mol%) were added and 
stirring continued for another 18 h at ambient temperature. The mixture was poured into aq. sat. NH4Cl 
(20 mL), the aqueous layer was extracted with Et2O (3 x 30 mL), and the combined extracts were dried 
(Na2SO4) and concentrated. Purification of the residue by flash chromatography (hexanes/EtOAc, 95:5 → 
9:1) gave the title compound as a white solid (165 mg, 68%). Mp = 79-80 °C; 1H NMR (400 MHz, CDCl3): δ 
= 1.33 (t, J = 7.1 Hz, 3H), 4.26 (q, J = 7.1 Hz, 2H), 5.99 (s, 2H), 6.00 (d, J = 16.2 Hz, 1H), 6.78 (d, J = 8.0 Hz, 
1H), 6.87 (dd, J = 8.1, 1.7 Hz, 1H), 6.92 (d, J = 1.7 Hz, 1H), 7.14 (d, J = 16.2 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δ = 14.1, 61.9, 82.1, 86.3, 101.5, 102.5, 105.4, 108.5, 123.0, 129.6, 147.3, 148.4, 149.3, 154.1; IR 
S17 
 
(film): ?̃? = 2197, 1710, 1621, 1595, 1503, 1490, 1442, 1366, 1248, 1194, 1131, 1094, 1037, 1011, 946, 
932, 852, 800, 742 cm1; MS (EI) m/z (%): 244 (100), 229 (5), 216 (7), 199 (61), 185 (4), 171 (66), 157 (3), 
141 (12), 129 (3), 113 (41), 99 (34), 87 (10), 75 (6), 63 (24), 51 (5), 39 (5), 29 (11); HRMS (EI): m/z: calcd. 
for C14H12O4Na [M+Na
]: 267.06278, found: 267.06258. 
Compound 22. t-Butyl acetate (234 mg, 2 mmol) was added dropwise to a stirred solution of LDA (0.5 M 
in THF, 4 mL, 2.0 mmol) at 78 °C. The mixture was stirred at this 
temperature for 30 min before a solution of compound 21 (244 mg, 1.0 
mmol) in THF (1 ml) was added. Stirring was continued at 78 °C for 3 h 
before the reaction was quenched with sat. aq. NH4Cl (20 mL). The 
aqueous phase was extracted with Et2O (3 x 20 mL), and the combined extracts were dried (Na2SO4) and 
concentrated. Purification of the residue by flash chromatography (hexanes/EtOAc, 9:1→4:1) gave the 
title compound as a yellow oil (280 mg, 89%). 1H NMR (ketone form, 400 MHz, CDCl3): δ = 1.49 (s, 9H), 
3.52 (s, 2H), 6.00 (s, 2H), 6.05 (d, J = 16.2 Hz, 1H), 6.79 (d, J = 8.0 Hz, 1H), 6.90 (dd, J = 8.0, 1.6 Hz, 1H), 
6.95 (d, J = 1.6 Hz, 1H), 7.16 (d, J = 16.2 Hz, 1H); characteristic signals of the enol form: δ = 1.50 (s, 9H), 
5.28 (s, 1H), 5.98 (s, 2H), 6.07 (d, J = 16.2 Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 6.86 (dd, J = 8.0, 1.6 Hz, 1H), 
6.93 (d, J = 1.6 Hz, 1H), 7.02 (d, J = 16.2 Hz, 1H), 12.05 (s, 1H); 13C NMR (ketone form, 100 MHz, CDCl3): δ 
= 27.9, 52.6, 82.2, 89.4, 93.0, 101.6, 102.6, 105.5, 108.6, 123.4, 129.5, 148.4, 148.4, 149.6, 165.4, 179.0; 
characteristic signals of the enol form:  = 28.3, 80.4, 82.2, 85.3, 98.3,101.4, 103.9, 105.3, 108.5, 122.6, 
130.1, 144.6, 148.3, 148.9, 154.9, 172.0; IR (film): ?̃? = 2979, 2903, 2170, 1729, 1663, 1619, 1589, 1504, 
1490, 1447, 1392, 1366, 1287, 1250, 1148, 1102, 1035, 952, 928, 893, 833, 798, 761 cm1; MS (EI) m/z 
(%): 314 (29), 258 (100), 240 (19), 227 (3), 214 (19), 199 (88), 188 (31), 169 (32), 157 (15), 141 (11), 127 
(14), 113 (31), 99 (16), 87 (6), 77 (5), 63 (12), 57 (63), 41 (20), 29 (14); HRMS (EI): m/z: calcd. for 
C18H18O5Na [M+Na
]: 337.10465, found: 337.10462. 
Compound 23. The solution of compound 22 (386 mg 1.23 mmol) and SPhosAuNTf2 (22 mg, 25 µmol, 2 
mol%) in acetic acid (8 mL) was stirred for 2 h. The mixture was concentrated and 
the resulting solid was rinsed with cold Et2O (3 x 5 mL) and dried under vacuum to 
give the title compound as a yellow solid (286 mg, 90%). Because of the low 
solubility, flash chromatography results in loss of material. Mp = 239-242°C 
(decomp.); 1H NMR (400 MHz, [D6]-DMSO): δ  5.30 (d, J = 2.0 Hz, 1H), 6.07 (s, 2H), 
6.13 (d, J = 1.8 Hz, 1H), 6.88 (d, J = 16.0 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H), 7.14 (dd, J = 8.1, 1.4 Hz, 1H), 7.23 
(d, J = 16.0 Hz, 1H), 7.33 (d, J = 1.4 Hz, 1H), 11.69 (br s, 1H); 13C NMR (100 MHz, [D6]-DMSO): δ  89.6, 
101.1, 101.4, 106.0, 108.5, 118.0, 123.6, 129.7, 133.9, 148.0, 148.4, 159.4, 162.9, 170.1; IR (film): ~  = 
1699, 1631, 1606, 1555, 1499, 1479, 1443, 1357, 1299, 1254, 1241, 1157, 1100, 1036, 1009, 959, 924, 
840, 815, 796, 683 cm1; MS (EI) m/z (%): 258 (100), 241 (7), 230 (6), 214 (21), 199 (11), 188 (45), 175 
(30), 160 (25), 145 (25), 130 (16), 117 (16), 102 (12), 89 (35), 77 (6), 69 (26), 51 (10), 39 (11), 29 (5); 
HRMS (ESI): m/z: calcd. for C14H10O5Na [M+Na
]: 281.0420, found: 281.0421. 
Compound S-6. LiAlH4 (4.15 g, 109.1 mmol) was added in portions to a cold (0°C) solution of ester 27 
(10.0 g, 54.5 mmol) in THF (200 mL). Stirring was continued for 2 h at 0°C before the 
mixture is allowed to reach ambient temperature. The reaction was carefully quenched by 
slow addition of water (4 mL) and aq. NaOH (15% w/w, 4 mL). The resulting mixture was 
vigorously stirred for 1 h before the insoluble material was filtered off and carefully rinsed with EtOH (ca. 
50 mL). The combined filtrates were evaporated and the residue was purified by distillation, collecting 
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the fraction boiling at 76-80°C (10 mbar). The product was thus obtained as a colorless liquid (7.56 g, 
90%). 1H NMR (400 MHz, CDCl3): δ = 4.94 (d, J = 1.8 Hz, 1H), 4.74 (d, J = 1.8 Hz, 1H), 3.69 (b, 1H), 3.61 
(t, J = 10.6 Hz, 1H), 2.10 (t, J = 6.4 Hz, 2H), 2.03 (dd, J = 10.8 Hz, 4.8 Hz, 1H), 1.62-1.48 (m, 2H), 1.45-1.35 
(m, 2H), 1.29-1.22 (m, 1H), 0.94 (s, 3H), 0.85 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 147.5, 111.7, 59.6, 
56.4, 36.3, 33.8, 31.8, 29.8, 26.5, 23.1; MS (EI) m/z (%): 139 (6) [M+ - Me], 136 (36), 121 (62), 109 (34), 
95 (25), 93 (83), 81 (54), 79 (30), 69 (100), 67 (34), 55 (26), 53 (12), 41 (52), 29 (11). 
Compound S-7. Oxalyl chloride (10.1 mL, 117.6 mmol) was added dropwise to a solution 
of DMSO (13.9 mL, 196.1 mmol) in CH2Cl2 (120 mL) at 78°C. The mixture was stirred for 
15 min at this temperature before a solution of compound S-6 (12.1 g, 78.4 mmol) in 
CH2Cl2 (5 mL) was added over the course of 5 min. Stirring was continued at 78°C for 3 h before Et3N (44 
mL, 313.7 mmol) was introduced and the mixture allowed to reach ambient temperature. The reaction 
was then quenched with water (200 mL), the aqueous phase was repeatedly extracted with tert-butyl 
methyl ether, and the combined organic layers were dried over Na2SO4 and evaporated.  
The residue was dissolved in toluene (200 mL) and Ph3P=CC(O)Me (34.9 g, 109.8 mmol) was added. The 
resulting mixture was stirred at reflux temperature for 16 h. After reaching ambient temperature, hexane 
(60 mL) was introduced and the precipitate was filtered off. The filtrate was evaporated and the residue 
purified by flash chromatography (hexanes/EtOAc, 20:1) to give the title compound as a colorless liquid 
(10.1 g, 67%). 1H NMR (400 MHz, CDCl3): δ = 6.93 (dd, J = 15.8 Hz, 10.0 Hz, 1H), 6.08 (d, J = 15.8 Hz, 1H), 
4.79 (t, J = 1.1 Hz, 1H), 4.54 (s, 1H), 2.58 (d, J = 10.0 Hz, 1H), 2.31-2.21 (m, 1H), 2.26 (s, 3H), 2.11-2.01 (m, 
1H), 1.63-1.55 (m, 2H), 1.54-1.45 (m, 1H), 1.40-1.29 (m, 1H), 0.90 (s, 3H), 0.86 (s, 3H); 13C NMR (100 
MHz, CDCl3): δ = 198.2, 148.3, 147.1, 132.7, 109.6, 57.5, 38.6, 35.5, 34.1, 29.2, 27.2, 23.9, 23.1; IR 
(film): ?̃? = 3077, 2930, 2867, 1697, 1672, 1644, 1624, 1437, 1386, 1361, 1252, 1231, 1176, 1139, 988, 
889, 849, 705 cm-1; MS (EI) m/z (%): 192 (17) [M+], 177 (17), 164 (12), 149 (64), 135 (9), 121 (47), 109 
(39), 93 (22), 81 (45), 69 (56), 65 (13), 53 (14), 43 (100), 27 (15). 
Compound S-8. Bu3SnH (2.3 mL, 8.47 mmol) was added over 20 min to a solution of compound S-7 (814 
mg, 4.24 mmol), (Ph3P)2PdCl2 (150 mg, 0.21 mmol, 5 mol%), NH4Cl (522 mg, 9.75 mmol) 
and water (206 mg, 11.45 mmol) in THF (50 mL). The resulting mixture was stirred for 3 
h before it was diluted with Et2O (50 mL) and brine (30 mL). The organic phase was 
evaporated and the residue was dissolved in EtOAc (25 mL). An aq. sat. solution of NaF 
(30 mL) was added and the resulting mixture was vigorously stirred for 5 h. Insoluble materials were then 
filtered off. The organic phase was separated and concentrated, and the residue was purified by flash 
chromatography (hexanes/EtOAc, 20:1) to give the title compound as a pale yellow liquid (623 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ = 4.78 (t, J = 1.0 Hz, 1H), 4.49 (d, J = 2.4 Hz, 1H), 2.38-2.31 (m, 1H), 2.30-
2.24 (m, 1H), 2.09 (s, 3H), 2.02-1.94 (m, 2H), 1.84-1.73 (m, 1H), 1.71-1.64 (m, 1H), 1.60-1.42 (m, 4H), 
1.23-1.15 (m, 1H), 0.90 (s, 3H), 0.86 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 209.3, 149.0, 109.4, 53.4, 
42.3, 35.7, 34.8, 32.0, 30.1, 28.2, 26.5, 23.5, 20.2; MS (EI) m/z (%): 194 (4) [M+], 176 (31), 161 (29), 147 
(2), 136 (100), 121 (70), 109 (28), 105 (51), 95 (52), 79 (32), 67 (13), 55 (13), 43 (56), 27 (5); HRMS (EI): 
m/z: calcd. 194.1669; found: 194.1671. 
Compound 28. A solution of ethynylmagnesium bromide (0.5 M in THF, 9.6 mL, 4.8 mmol) was slowly 
added to a solution of compound S-8 (623 mg, 3.21 mmol) in THF (30 mL) at 0°C. The 
ice bath was removed and the mixture stirred for 30 min. The reaction was quenched 
with sat. aq. NH4Cl (30 mL), the aqueous phase was repeatedly extracted with EtOAc, the 
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combined organic layers were dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (hexanes/EtOAc, 10:1) to give the title compound as a colorless liquid (670 mg, 95%). 1H 
NMR (400 MHz, CDCl3, mixture of diastereoisomers): δ = 4.78 – 4.73 (m, 1H), 4.58 – 4.54 (m, 1H), 2.43 (s, 
1H), 2.078 – 1.87 (m, 3H); 1.74 – 1.36 (m, 8H), 1.48 (d, J = 0.8 Hz, 3H), 1.24 – 1.19 (m, 1H), 0.93 (s, 3H), 
0.86 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 149.1, 109.13 109.1, 87.9, 87.8, 71.2, 68.22, 68.16, 54.1, 
54.0, 42.2, 42.1, 36.23, 36.2, 35.0, 32.42, 32.37, 30.0, 29.7, 28.39, 28.38, 26.2, 23.65, 23.64, 21.20, 
21.15. MS (EI) m/z (%): 205 (5), 187 (27), 177 (4), 159 (18), 145 (17), 131 (30), 121 (30), 109 (47), 93 (50), 
81 (42), 69 (100), 55 (32), 41 (61), 29 (10); HRMS (EI): m/z: calcd. for [M++H]: 221.1903; found: 221.1905. 
Compound 29. A sealed flask containing a solution of compound 28 (626 mg, 2.84 mmol), (Ph3SiO)3V=O 
(127 mg, 0.14 mmol, 5 mol%) and Ph3SiOH (24 mg, 0.09 mmol, 3mol%) in toluene 
(7.5 mL) was heated in a microwave oven at 120°C for 1.5 h. For work up, all volatile 
materials were evaporated and the residue was purified by flash chromatography 
(hexanes/EtoAc, 20:1) to give the title compound as a pale yellow liquid (509 mg, 81%). 
1H NMR (400 MHz, CDCl3): δ = 9.89 (d, J = 8.3 Hz, 1H), 5.85 (d, J = 8.2 Hz, 1H), 4.83 (d, J = 1.0 Hz, 1H), 
4.57 (d, J = 1.1 Hz, 1H), 2.09-2.01 (m, 2H), 1.97 (s, 3H), 1.77-1.39 (m, 7H), 1.29-1.17 (m, 2H), 0.93 (s, 
3H), 0.84 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 190.9, 165.1, 148.6, 128.4, 109.7, 53.8, 36.2, 34.9, 
32.4, 31.3, 28.3, 26.1, 25.6, 24.9, 23.6; MS (EI) m/z (%): 220 (3) [M+], 205 (24), 187 (11), 176 (61), 161 
(39), 149 (9), 137 (36), 121 (36), 109 (58), 105 (34), 95 (74), 81 (100), 69 (89), 55 (43), 41 (89), 29 (17); 
HRMS (EI): m/z: calcd. 220.1828; found: 220.1827. 
Compound 25. A solution of aldehyde 29 (163 mg, 0.74 mmol), acetic acid anhydride (97 mg, 0.96 
mmol) and piperidine (82 mg, 0.96 mmol) in EtOAc (35 mL) was stirred 
in a closed pressure flask at 85°C bath temperature for 1 h. A solution 
of pyrone 23 (190 mg, 0.74 mmol) in EtOAc (15 mL) was then added 
and stirring continued at 85°C for another 3 h. After reaching ambient 
temperature, the solvent was evaporated and the residue was purified 
by flash chromatography (hexanes/EtOAc, 10:1) to give the title 
compound as a 1:1 mixture of diastereomers in the form of a yellow solid (280 mg, 82%). 1H NMR (400 
MHz, CDCl3): δ = 7.41 (d, J = 15.8 Hz, 1H), 7.00 (s, 1H), 6.98 (d, J = 8.1 Hz, 1H), 6.81 (d, J = 8.0 Hz, 1H), 
6.47 (d, J = 10.1 Hz, 1H), 6.39 (d, J = 15.8 Hz, 1H), 6.00 (s, 2H), 5.90 (s, 1H), 5.34 (d, J = 10.1 Hz, 1H), 4.79 
– 4.73 (m, 1H), 4.54 (d, J = 2.2 Hz, 1H), 2.09 – 2.12 (m, 2H), 1.80 – 1.33 (m, 8H), 1.41 (s, 3H), 1.27 – 1.16 
(m, 1H), 0.91 (s, 3H), 0.82 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 164.3, 164.2, 161.8, 158.9, 149.11, 
149.08, 149.0, 148.5, 135.3, 129.9, 124.6, 124.4, 123.7, 117.3, 117.10, 117.06, 109.4, 109.3, 108.8, 
105.9, 101.6, 100.81, 100.78, 99.3, 83.2, 83.0, 54.21, 54.15, 40.6, 40.5, 36.4, 36.2, 35.14, 35.07, 32.6, 
32.4, 28.50, 28.48, 27.7, 27.5, 26.4, 26.2, 23.72, 23.70, 20.5, 20.4; MS (EI) m/z (%): 460 (34) [M+], 337 (3), 
309 (100), 271 (11), 175 (11), 145 (6), 117 (3), 89 (3), 69 (3), 41 (4); HRMS (ESI): m/z: calcd. for [M+ + Na]: 
483.2138; found: 483.2142. 
Compound 26. BCl3 (1 M in CH2Cl2, 250 µL, 0.25 mmol) was added to a solution of compound 25 (23 mg, 
0.05 mmol) and the resulting mixture was stirred at 50°C for 16 h. 
After reaching ambient temperature, MeOH (1 mL) was introduced 
and stirring continued for 1 h at 40°C. Next, all volatile materials were 
evaporated and the residue was purified by flash chromatography 
(hexanes/acetone, 1:1) to give the product as an inseparable 1:1 
S20 
 
mixture of diastereoisomers in the form of a yellow, sparingly soluble solid material (8 mg, 36%). 1H 
NMR (600 MHz, CD3OD): δ = 7.29 (d, J = 15.9 Hz, 1H), 7.02 (d, J = 2.0 Hz, 1H), 6.94 (dd, J = 8.2, 2.0 Hz, 
1H), 6.76 (d, J = 8.2 Hz, 1H), 6.59 (d, J = 15.9 Hz, 1H), 6.40 (dd, J = 10.2, 3.4 Hz, 1H), 6.14 (d, J = 2.6 Hz, 
1H), 5.48 (d, J = 10.1 Hz, 1H), 5.44 (d, J = 10.1 Hz, 1H), 4.78 – 4.76 (m, 1H), 4.58 – 4.54 (m, 1H), 2.05 -2.02 
(m, 1H), 1.79 – 1.38 (m, 9H), 1.42 (s, 3H), 1.26 – 1.18 (m, 1H), 0.92 (s, 3H), 0.82 (s, 3H); 13C NMR (150 
MHz, CD3OD): δ = 166.70, 166.67, 163.86, 163.85, 161.4, 150.4, 148.8, 146.8, 137.37, 137.36, 128.9, 
126.1, 125.9, 122.1, 117.4, 117.3, 116.83, 116.81, 116.6, 114.9, 110.0, 109.9, 101.1, 99.4, 84.6, 84.5, 
55.43, 55.42, 41.62, 41.59, 37.3, 37.2, 35.9, 35.8, 33.4, 33.3, 28.84, 28.83, 27.9, 27.8, 26.7, 24.7, 21.6, 
21.5; MS (EI) m/z (%): 471 (100) [M+ + Na]; HRMS (ESI): m/z: calcd. for [M+ + Na]: 471.2146; found: 
471.2142. 
 
The Radicinol Family 
6-(4-Methylbenzenesulfonate)-phenyl-1-thio-β-D-glucopyranoside (S-9). Tosyl chloride (10.50 g, 55.08 
mmol) was added in one portion to a solution of compound 33 (10.00 g, 57.06 mmol) 
in pyridine (65 mL) at 0°C. The mixture was stirred for 13 h at 0°C before it was 
concentrated. The residue was dissolved in CH2Cl2 and the organic phase was washed 
with sat. aq. NaHCO3 and brine, dried over MgSO4 and evaporated. The residue was purified by flash 
chromatography (CH2Cl2/CH3OH, 1:0 to 6:1) to give the title compound as a white foam (10.66 g, 68%). 
[𝑎]D
20: –36.7 (c = 1, CHCl3).
1H NMR (400 MHz, CDCl3): δ = 7.84 – 7.78 (m, 2H), 7.50 – 7.45 (m, 2H), 7.36 – 
7.26 (m, 5H), 4.46 (d, J = 9.8 Hz, 1H), 4.36 – 4.27 (m, 2H), 3.59 – 3.45 (bm, 3H), 3.32 – 3.24 (m, 1H), 3.13 
– 2.98 (bm, 1H), 2.97 – 2.85 (bm, 1H), 2.71 – 2.60 (bm, 1H), 2.43 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 
145.2, 133.1, 132.8, 131.4, 130.1, 129.2, 238.5, 128.2, 88.0, 77.5, 77.2, 71.7, 69.2, 21.8. IR (film): ?̃? = 
3392, 1480, 1440, 1360, 1190, 1175, 1095, 1042, 1020, 973, 903, 814, 724, 650 cm-1. HRMS (ESI): m/z: 
calcd. for C19H22O7S2Na
+: 449.06992; found: 449.06992.  
6-(4-Methylbenzenesulfonate)-2,3,4-tris-O-benzyl-phenyl-1-thio-β-D-glucopyranoside (34). NaH (1.90 
g, 79.14 mmol) was added in portions to a solution of compound S-9 (8.27 g, 19.38 mmol) in DMF (100 
mL) at 0°C. The mixture was stirred at 0°C for 1 h before benzyl bromide (10 mL, 
171.04 mmol) was slowly added. Stirring was continued for 18 h at ambient 
temperature. For work up, the solvent was removed in vacuo and the residue was 
dissolved in tert-butyl methyl ether. The organic layer was washed with sat. aq. NH4Cl and brine, dried 
over MgSO4, and evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 5:1) 
afforded the title compound as a white solid (11.75 g, 87%). [𝑎]D
20: –0.1 (c = 1, CHCl3). 
1H NMR (400 MHz, 
CDCl3): 7.81 – 7.76 (m, 2H), 7.53 – 7.45 (m, 2H), 7.39-7.26 (m, 18H), 7.21 – 7.16 (m, 2H), 4.87 (t, J = 10.1 
Hz, 2H), 4.81 (dd, J = 10.9, 2.5 Hz, 2H), 4.69 (d, J = 10.3 Hz, 1H), 4.56 (d, J = 9.8 Hz, 1H), 4.53 (d, J = 10.8 
Hz, 1H), 4.30 – 4.23 (m, 1H), 4.20 – 4.15 (m, 1H), 3.69 – 3.62 (m, 1H), 3.54 ‒ 3.46 (m, 2H), 3.46 – 3.38 (m, 
1H), 2.39 (s, 3H). 13C NMR (101 MHz, CDCl3): δ = 145.0, 138.3, 138.0, 137.6, 133.2, 132.9, 132.4, 130.0, 
129.1, 128.7, 128.64, 128.60, 128.4, 128.3, 128.2, 128.1, 128.0, 127.91, 127.86, 87.4, 86.6, 80.6, 76.9, 
76.6, 76.0, 75.6, 75.3, 68.5, 21.8. IR (film): ?̃? = 3063, 3030, 1598, 1585, 1454, 1363, 1190, 1177, 1093, 
1067, 1028 cm-1. HRMS (ESI): m/z: calcd. for C40H40O7S2Na




6-Deoxy-2,3,4-tris-O-benzyl-phenyl-1-thio-β-D-glucopyranoside (S-10). LiAlH4 (2.02 g, 53.16 mmol) was 
added in one portion to a solution of compound 34 (9.26 g, 13.29 mmol) in THF (133 
mL) and the resulting mixture was stirred at reflux temperature for 2 h. After cooling to 
room temperature, the reaction was quenched by the careful addition of EtOAc and 
water. The aqueous phase was extracted with tert-butyl methyl ether, the combined extracts were 
washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 10:1) afforded the 
title compound as a white solid (6.23 g, 89%). [𝑎]D
20: +10.8 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 
7.58 – 7.52 (m, 2H), 7.41‒7.26 (m, 18H), 4.94 – 4.82 (m, 4H), 4.74 (d, J = 10.4 Hz, 1H), 4.66 (d, J = 10.1 Hz, 
2H), 3.68 (t, J = 9.0 Hz, 1H), 3.53 – 3.46 (m, 1H), 3.45 – 3.38 (m, 1H), 3.23 (t, J = 9.3 Hz, 1H), 1.35 (d, J = 
6.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 138.5, 138.2, 134.0, 132.0, 129.1, 128.6, 128.6, 128.4, 128.2, 
128.03, 128.00, 127.9, 127.6, 87.6, 86.7, 83.4, 81.4, 76.0, 75.8, 75.6, 75.5, 18.3. IR (film): ?̃? = 3062, 3030, 
2900, 2867, 1584, 1497, 1454, 1360, 1130, 1089, 1069, 737, 697 cm-1. HRMS (ESI): m/z: calcd. for 
C33H34O4SNa
+: 549.20700; found: 549.20700.  
 6-Deoxy-2,3,4-tris-O-benzyl-1-(phenylsulfinyl)-β-D-glucopyranoside (35a,b). A solution of mCPBA (1.25 
g, 5.58 mmol) in CH2Cl2 (30 mL) was added dropwise over 30 min to a solution of S-10 
(2.10 g, 3.99 mmol) in CH2Cl2 (30 mL) at –20°C. The resulting mixture was stirred at 
20°C for 12 h before the reaction was quenched with sat. aq. Na2S2O3. The mixture 
was warmed to RT and extracted with tert-butyl methyl ether. The combined extracts 
were washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 5:1) afforded the 
diastereomeric sulfoxides 35a (730 mg) and 35b (1.31 g) as white solids each (94%, d.r.: 1:1.8).  
Analytical and spectral data of the minor isomer 35a: [𝑎]D
20: +21.4 (c = 1, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 7.59 (m, 2H), 7.46-7.21 (m, 16H), 7.12 (m, 2H), 4.82 (m, 5H), 4.61 (d, J = 10.9 Hz, 1H), 4.67 (m, 
1H), 3.78 (m, 2H), 3.52 (m, 1H), 3.12 (m, 1H), 1.31 (d, J = 6.1 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 
140.2, 138.1, 137.8, 131.0, 128.8, 128.6, 128.3, 128.1, 127.9, 127.8, 127.7, 127.6, 125.5, 95.3, 86.5, 83.0, 
76.5, 76.2, 75.6, 75.4, 74.1, 17.9. IR (film): ?̃? = 3062, 3030, 2872, 1497, 1454, 1360, 1131, 1086, 1046, 
1029, 999, 735, 696 cm-1. HRMS (ESI): m/z: calcd. for C33H34O5SNa
+: 565.20192; found: 565.20192.  
Analytical and spectral data of the major isomer 35b: [𝑎]D
20: –83.0 (c = 1, CHCl3). 
1H NMR (400 MHz, 
CDCl3): δ = 7.63 (m, 2H), 7.50 (m, 3H), 7.42 - 7.22 (m, 15H), 4.99 (q, J = 9.9 Hz, 2H), 4.93 (q, J = 10.2 Hz, 
2H), 4.83 (d, J = 10.8 Hz, 1H), 4.62 (d, J = 10.8 Hz, 1H), 4.08 (t, J = 9.3 Hz, 1H), 3.88 (d, J = 10.9 Hz, 1H), 
3.74 (t, J = 9.0 Hz, 1H), 3.28 (t, J = 9.1 Hz, 1H), 3.20 (m, 1H), 1.11 (d, J = 6.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ = 139.8, 138.4, 137.9, 137.7, 131.1, 128.9, 128.7, 128.66, 128.61, 128.5, 128.3, 128.1, 127.9, 
127.8, 125.4, 93.6, 86.5, 82.9, 77.2, 76.8, 76.0, 75.8, 75.5, 17.6. IR (film): ?̃? = 3063, 3031, 2873, 1497, 




arabino-hex-1-enitol (37a). nBuLi (1.6 M in hexanes, 3.3 mL, 5.28 mmol) was added 
dropwise to a solution of diisopropylamine (890 µL, 6.35 mmol) in THF (59 mL) at 0°C 
and the resulting mixture was stirred for 15 min at this temperature. The mixture was 
then cooled to –78°C and a solution of 35a (570 mg, 1.05 mmol) in THF (117 mL) was 
added dropwise over 30 min. Stirring was continued at this temperature for 1 h before 
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HMPA (183 µL, 1.05 mmol) was injected, followed by TeocCl (573 µL, 3.15 mmol). After stirring for an 
additonal 1.5 h at –78 °C, the reaction was quenched with sat. aq. NH4Cl, the mixture was warmed to 
room temperature and the aqueous layer extracted with tert-butyl methyl ether. The combined extracts 
were washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 2:1) afforded product 
37a as a colorless solid (600 mg, 99%). [𝑎]D
20: –265.2 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.98 – 
7.91 (m, 2H), 7.51 ‒ 7.42 (m, 2H), 7.40 – 7.26 (m, 9H), 7.22 – 7.14 (m, 2H), 4.82 – 4.73 (m, 1H), 4.61 – 
4.47 (m, 4H), 4.45 (dd, J = 2.5, 1.8 Hz, 1H), 4.36 – 4.21 (m, 2H), 3.52 (t, J = 2.6 Hz, 1H), 1.14 – 0.96 (m, 
5H), 0.06 (s, 9H). 13C NMR (101 MHz, CDCl3): δ = 165.9, 165.7, 143.4, 138.0, 137.5, 131.0, 129.0, 128.7, 
128.6, 128.1, 128.05, 127.96, 127.9, 125.7, 106.8, 76.7, 75.0, 73.0, 72.5, 71.7, 63.8, 17.8, 14.9, –1.4. IR 
(film): ?̃? = 2952, 1695, 1600, 1454, 1381, 1298, 1250, 1205, 1140, 1083, 1055 cm-1. HRMS (ESI): m/z: 
calcd. for C32H38O6SSiNa
+: 601.20506; found: 601.20506.  
 1,5-Anhydro-2,6-dideoxy-2-(2-trimethylsilyl-ethoxycarbonyl)-3,4-bis-O-benzyl-1-C-(phenylsulfinyl)-D-
arabino-hex-1-enitol (37b, diastereomeric sulfoxide). Prepared analogously starting 
from 35b (778 mg, 1.43 mmol) as a colorless syrup (796 mg, 96%). [𝑎]D
20: +71.5 (c = 1, 
CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.78 (m, 2H), 7.40 (tt, J = 7.3, 1.6 Hz, 1H), 7.36-
7.26 (m, 10H), 7.03 (m, 2H), 4.83 (qt, J = 2.3, 1.9 Hz, 1H), 4.69 (d, J = 11.4 Hz, 1H), 4.59 
(d, J = 11.6 Hz, 1H), 4.42 (d, J = 11.6 Hz, 1H), 4.33 (d, J = 11.6 Hz, 1H), 4.29 (t, J = 2.4 Hz, 
1H), 4.16 (m, 2H), 3.58 (t, J = 2.3 Hz, 1H), 1.52 (d, J = 7.3 Hz, 3H), 0.96 (m, 2H), 0.00 (s, 9H). 13C NMR (101 
MHz, CDCl3): δ = 167.1, 166.3, 144.4, 138.1, 137.6, 131.1, 129.1, 128.6, 128.5, 128.13, 128.08, 127.9, 
127.3, 126.6, 104.7, 77.7, 74.9, 73.2, 71.3, 71.2, 63.4, 17.6, 16.1, –1.4. IR (film): ?̃? = 3062, 3030, 2953, 
1694, 1597, 1454, 1298, 1261, 1207, 1073, 1056 cm-1. HRMS (ESI): m/z: calcd. for C32H38O6SSiNa
+: 
601.20506; found: 601.20506.  
 1,5-Anhydro-2,6-dideoxy-2-(2-trimethylsilyl-ethoxycarbonyl)-3,4-bis-O-benzyl-1-C-((E)-pent-3-en-1-
yn)-D-arabino-hex-1-enitol (39). This reaction was performed in the dark. nBuLi (1.6 M in hexanes, 3.00 
mL, 4.80 mmol) was added dropwise to a solution of (E)-1,1-dibromopenta-1,3-
diene (537 mg, 2.38 mmol)2 in THF (3 mL) at –78°C. The mixture was stirred at –78 
°C and at 0 °C for 1 h each. After re-cooling to –78°C, a solution of 37a (275 mg, 
0.48 mmol) in THF (3 mL) was added dropwise and stirring was continued at –78°C 
for 30 min and at ‒55°C for an additional 16 h. The reaction was quenched with 
sat. aq. NH4Cl while cold, the mixture was warmed to room temperature and the aqueous layer was 
extracted with tert-butyl methyl ether. The combined extracts were washed with brine and dried over 
MgSO4. The drying agent was filtered off and the solvent was evaporated. Purification of the residue by 
flash chromatography (hexanes/EtOAc, 10:1) afforded the title compound as a yellow oil (203 mg, 82%). 
When applied to compound 37b (248 mg, 0.43 mmol), the same product was obtained in 85% yield (190 
mg). [𝑎]D
20: –13.0 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 7.37 – 7.26 (m, 10H), 6.36 (dq, J = 15.7, 
6.9 Hz, 1H), 5.69 (dq, J = 15.7, 1.7 Hz, 1H), 4.69 (d, J = 11.4 Hz, 1H), 6.64 – 4.55 (m, 3H), 4.55 – 4.52 (m, 
1H), 4.50 – 4.42 (m, 1H), 4.31 – 4.20 (m, 2H), 3.59 (t, J = 3.4 Hz, 1H), 1.84 (dd, J = 7.1, 1.8 Hz, 3H), 1.40 (d, 
J = 7.1 Hz, 3H), 1.06 – 0.99 (m, 2H), 0.04 (s, 9H). 13C NMR (101 MHz, CDCl3): δ = 166.9, 144.8, 143.5, 
138.7, 137.9, 128.6, 128.4, 128.0, 127.9, 127.74, 127.70, 110.1, 109.8, 94.3, 82.3, 75.7, 74.8, 72.7, 72.2, 
71.9, 62.7, 19.1, 17.7, 16.7, –1.4. IR (film): ?̃? = 2951, 2208, 1688, 1594, 1454, 1381, 1324, 1249, 1146, 
1069 cm-1. HRMS (ESI): m/z: calcd. for C31H38O5SiNa




pyran-5-one (42b, R = Me) and (2R,3R,4R)-3-(benzyloxy)-4-methoxy-2-methyl-7-((E)-prop-1-en-1-yl)-
3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-5-one (epi-42b, R = Me). SPhosAuNTf2 (1.6 mg, 0.002 mmol, 1 
mol%) was added to a solution of compound 39 (100 mg, 0.19 mmol) in CH3OH (1.85 mL). The mixture 
was stirred for 2 h before conc. HCl (50 µL, 0.61 mmol) was added dropwise. Stirring was continued for 
18 h. The reaction was quenched with sat. aq. NH4Cl and the aqueous layer extracted with tert-butyl 
methyl ether. The combined extracts were washed with brine and dried over MgSO4. The drying agent 
was filtered off and the solvent was evaporated. Purification of the residue by flash chromatography 
(hexanes/EtOAc, 5:1) afforded 42b (R = Me, 44 mg, 67%) and epi-42b (R = Me, 16 mg, 24%). 
 Analytical and spectral data of 42b (R = Me): [𝑎]D
20: +58.2 (c = 1, CHCl3). 
1H NMR 
(400 MHz, CD2Cl2): δ = 7.41 – 7.28 (m, 5H), 6.66 (dq, J = 15.5, 6.9 Hz, 1H), 5.98 (dq, 
J = 15.4, 1.6 Hz, 1H), 5.71 (s, 1H), 4.80 (d, J = 11.6 Hz, 1H), 4.56 (d, J = 11.6 Hz, 1H), 
4.55 (d, J = 3.0 Hz, 1H), 4.29 (dq, J = 10.4, 6.3 Hz, 1H), 3.55 (s, 3H), 3.34 (dd, J = 
10.2, 2.9 Hz, 1H), 1.90 (dd, J = 7.1, 1.8 Hz, 3H), 1.45 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CD2Cl2): δ = 
166.2, 164.1, 159.4, 138.1, 135.5, 128.8, 128.3, 128.2, 123.2, 99.04, 98.99, 78.0, 72.1, 71.6, 67.3, 59.0, 
18.6, 17.9. IR (film): ?̃? = 2930, 1714, 1660, 1617, 1572, 1421, 1262, 1153, 1110, 1075 cm-1. HRMS (ESI): 
m/z: calcd. for C20H22O5Na
+: 365.13591; found: 365.13594.  
 Analytical and spectral data of epi-42b (R = Me): [𝑎]D
20: ‒4.2 (c = 1, CHCl3). 
1H 
NMR (400 MHz, CDCl3): δ = 7.39 – 7.28 (m, 5H), 6.70 (dq, J = 15.3, 7.0 Hz, 1H), 5.94 
(dq, J = 15.3, 1.5 Hz, 1H), 5.72 (s, 1H), 4.73 – 4.57 (m, 3H), 4.31 (t, J = 2.2 Hz, 1H), 
3.71 (t, J = 2.4 Hz, 1H), 3.48 (s, 3H), 1.89 (dd, J = 6.8, 1.5 Hz, 3H), 1.40 (d, J = 7.1 Hz, 
3H). 13C NMR (101 MHz, CDCl3): δ = 164.32, 164.27, 158.7, 137.4, 135.1, 128.7, 128.2, 128.0, 122.9, 99.4, 
97.7, 75.5, 73.8, 71.6, 69.8, 57.9, 18.6, 16.9. IR (film): ?̃? = 3031, 2934, 1717, 1660, 1618, 1572, 1424, 
1212, 1152, 1082, 1023 cm-1. HRMS (ESI): m/z: calcd. for C20H22O5Na
+: 365.135910; found: 365.135944.  
(2R,3R,4S)-3-(Benzyloxy)-2-methyl-5-oxo-7-((E)-prop-1-en-1-yl)-3,4-dihydro-2H,5H-pyrano[4,3-b]-
pyran-4-yl acetate (42a, R = Ac) and (2R,3R,4R)-3-(benzyloxy)-2-methyl-5-oxo-7-((E)-prop-1-en-1-yl)-
3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-4-yl acetate (epi-42a, R = Ac). SPhosAuNTf2 (1.4 mg, 0.002 
mmol, 1 mol%) was added to a solution of compound 39 (80 mg, 0.15 mmol) in glacial acetic acid (1.6 
mL) and the resulting mixture was stirred for 1 h at room temperature. The reaction was quenched with 
sat. aq. NaHCO3 and the aqueous phase extracted with tert-butyl methyl ether. The combined extracts 
were washed with brine and dried over MgSO4. The drying agent was filtered off and the solvent was 
evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 5:1) afforded 42a (R = 
Ac, 42 mg, 74%) and epi-42a (R = Ac, 5 mg, 9%). 
Analytical and spectral data of 42a (R = Ac): [𝑎]D
20: +138.1 (c = 1, CHCl3). 
1H NMR 
(400 MHz, CDCl3): δ = 7.38 – 7.28 (m, 5H), 6.73 (dq, J = 15.2, 7.1 Hz, 1H), 6.37 (d, J 
= 3.3 Hz, 1H), 5.94 (dq, J = 15.4, 1.6 Hz, 1H), 5.70 (s, 1H), 4.88 (d, J = 11.4 Hz, 1H), 
4.48 (d, J = 11.4 Hz, 1H), 4.30 (dq, J = 10.4, 6.2 Hz, 1H), 3.40 (dd, J = 10.1, 3.5 Hz, 
1H), 2.09 (s, 3H), 1.90 (dd, J = 7.1, 1.5 Hz, 3H), 1.42 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 
170.1, 166.9, 162.7, 159.7, 137.2, 136.2, 128.8, 128.6, 128.2, 122.8, 98.4, 96.8, 75.8, 72.19, 72.18, 59.9, 
21.2, 18.6, 17.7. IR (film): ?̃? = 3064, 3031, 2936, 1744, 1720, 1658, 1616, 1573, 1425, 1380, 1224, 1153, 
1010 cm-1. HRMS (ESI): m/z: calcd. for C21H22O6Na
+: 393.13086; found: 393.13086.  
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Analytical and spectral data of epi-42a (R = Ac): [𝑎]D
20: –26.2 (c = 1, CHCl3).
1H NMR 
(400 MHz, CDCl3): δ = 7.38 – 7.27 (m, 5H), 6.72 (dq, J = 15.3, 7.1 Hz, 1H), 5.96 (dq, J 
= 15.7, 1.6 Hz, 1H), 5.89 (t, J = 2.1 Hz, 1H), 5.75 (s, 1H), 4.81 (d, J = 12.1 Hz, 1H), 
4.69 (d, J = 12.1 Hz, 1H), 4.54 (qt, J = 2.3, 2.2 Hz, 1H), 3.69 (t, J = 2.5 Hz, 1H), 2.07 
(s, 3H), 1.90 (dd, J = 7.0, 1.6 Hz, 3H), 1.34 (d, J = 7.0 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 170.5, 165.1, 
162.9, 159.3, 137.5, 135.7, 128.6, 128.2, 128.1, 122.9, 99.1, 95.4, 75.6, 74.3, 71.9, 62.7, 21.1, 18.6, 16.7. 
IR (film): ?̃? = 2960, 2936, 1715, 1660, 1618, 1575, 1427, 1372, 1226, 1153, 1090, 1023 cm-1. HRMS (ESI): 
m/z: calcd. for C21H22O6Na
+: 393.13086; found: 393.13086.  
 (2R,3R,4R)-3,4-Bis(benzyloxy)-2-methyl-7-((E)-prop-1-en-1-yl)-3,4-dihydro-2H,5H-pyrano[4,3-b]-
pyran-5-one (40). SPhosAuNTf2 (0.4 mg, 0.0004 mmol, 1 mol%) was added to a 
solution of compound 39 (25 mg, 0.048 mmol) in nitromethane (0.4 mL) and the 
resulting mixture was stirred for 24 h. The reaction was quenched with sat. aq. 
NaHCO3 and the aqueous phase was extracted with CH2Cl2. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (hexanes/EtOAc, 5:1) 
afforded the title compound (19 mg, 94%). [𝑎]D
20: +13.7 (c = 1, CHCl3). 
1H NMR (400 MHz, CDCl3): δ = 
7.38 – 7.27 (m, 9H), 7.25 – 7.23 (m, 1H), 6.71 (dq, J = 15.3, 7.0 Hz, 1H), 5.95 (dq, J = 15.5, 1.5 Hz, 1H), 
5.73 (s, 1H), 4.87 (d, J = 11.6 Hz, 1H), 4.72 (d, J = 11.4 Hz, 1H), 4.63 – 4.55 (m, 3H), 4.46 (d, J = 12.1 Hz, 
1H), 3.68 (t, J = 2.4 Hz, 1H), 1.90 (dd, J = 7.1, 1.5 Hz, 3H), 1.44 (d, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
CDCl3): δ = 164.4, 164.3, 158.7, 138.8, 137.6, 135.1, 128.7, 128.5, 128.13, 128.08, 127.9, 127.7, 123.0, 
99.4, 98.1, 75.7, 75.1, 73.9, 71.7, 68.3, 18.6, 17.2. IR (film): ?̃? = 3031, 2934, 1706, 1660, 1618, 1573, 
1424, 1211, 1152, 1090, 1067, 1025 cm-1. HRMS (ESI): m/z: calcd. for C26H26O5Na
+: 441.16750; found: 
441.16724.  
 (2R,3S,4S)-3-(Benzyloxy)-4-hydroxy-2-methyl-7-((E)-prop-1-en-1-yl)-3,4-dihydro-2H,5H-pyrano[4,3-b]-
pyran-5-one (S-11). K2CO3 (109 mg, 0.79 mmol) was added in one portion to a 
solution of 42a (R = Ac, 29 mg, 0.08 mmol) in MeOH/H2O (1:1, 0.9 mL) and the 
resulting mixture was stirred at room temperature for 18 h. The mixture was 
diluted with water and the aqueous phase extracted with EtOAc. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (pentanes/EtOAc, 2:1) 
afforded the title compound as a colorless oil (23 mg, 90%). [𝑎]D
20: +61.7 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 7.40 – 7.30 (m, 5H), 6.72 (dq, J = 15.1, 7.1 Hz, 1H), 5.94 (dq, J = 15.5, 1.5 Hz, 1H), 5.71 (s, 
1H), 4.94 (d, J = 3.8 Hz, 1H), 4.82 (d, J = 11.9 Hz, 1H), 4.61 (d, J = 11.6 Hz, 1H), 4.40 (dq, J = 9.9, 6.3 Hz, 
1H), 3.77 (dd, J = 9.8, 3.6 Hz, 1H), 2.74 (bs, 1H), 1.89 (dd, J = 6.8, 1.5 Hz, 3H), 1.46 (d, J = 6.3 Hz, 3H). 13C 
NMR (101 MHz, CDCl3): δ = 166.1, 164.1, 159.3, 137.1, 135.8, 128.8, 128.4, 128.3, 122.8, 99.8, 98.7, 76.8, 
71.6, 71.4, 58.7, 18.6, 17.5. IR (film): ?̃? = 3443, 2932, 1690, 1659, 1617, 1572, 1428, 1265, 1151, 1086, 
1056 cm-1. HRMS (ESI): m/z: calcd. for C19H20O5Na
+: 351.12029; found: 351.12029.  
 (2R,3S,4R)-3-(Benzyloxy)-4-hydroxy-2-methyl-7-((E)-prop-1-en-1-yl)-3,4-dihydro-2H,5H-pyrano[4,3-b]-
pyran-5-one (S-12). Prepared analogously from compound epi-42a (R = Ac, 14 mg, 
0.04 mmol); colorless oil (12 mg, 97%). [𝑎]D
20: +12.6 (c = 1, CHCl3). 
1H NMR (400 
MHz, CDCl3): δ = 7.41 – 7.29 (m, 5H), 6.71 (dq, J = 15.0, 7.1 Hz, 1H), 5.96 (dq, J = 
15.6, 1.6 Hz, 1H), 5.76 (s, 1H), 5.01 (d, J = 11.4 Hz, 1H), 4.83 (d, J = 6.3 Hz, 1H), 4.76 (d, J = 11.4 Hz, 1H), 
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4.18 (dq, J = 8.1, 6.6 Hz, 1H), 4.18 – 4.03 (bs, 1H), 3.55 (dd, J = 8.3, 6.1 Hz, 1H), 1.91 (dd, J = 6.8, 1.5 Hz, 
3H), 1.46 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 164.7, 164.3, 158.7, 138.0, 135.6, 128.6, 
128.3, 128.0, 122.7, 101.2, 99.0, 78.8, 75.7, 73.9, 67.6, 18.6, 17.4. IR (film): ?̃? = 3460, 2927, 1687, 1573, 
1428, 1378, 1322, 1276, 1211, 1154, 1096, 1021 cm-1. HRMS (ESI): m/z: calcd. for C19H20O5Na
+: 
351.12029; found: 351.12029.  
 (+)-3-Methoxy-3-epi-radicinol (ent-32). BCl3 (1 M in CH2Cl2, 0.2 mL, 0.2 mmol) was added dropwise to a 
solution of 42b (R = Me, 22 mg, 0.06 mmol) in CH2Cl2 (0.6 mL) at ‒78°C. The 
mixture was stirred for 1 h at ‒78°C before the reaction was quenched with 
methanol and sat. aq. NH4Cl. The aqueous layer was extracted with EtOAc and the 
combined extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and 
the solvent was evaporated. Purification of the residue by flash chromatography (pentanes/EtOAc, 5:1) 
afforded ent-32 as a colorless oil (8 mg, 72%). [𝑎]D
20: +43.5 (c = 0.5, CHCl3) [Lit.
12 for 32: [𝑎]D
 : ‒65 (c =
5.8, CHCl3)]; for the NMR-spectroscopic data, see Table S-1; IR (film): ?̃? = 3428, 2926, 2855, 1709, 1572, 
1426, 1366, 1261, 1203, 1082, 1063 cm-1. HRMS (ESI): m/z: calcd. for C13H16O5Na
+: 275.08892; found: 
275.08899. 
Table S-1. Assigned spectral data (CDCl3, 500 MHz/126 
MHz) of 3-methoxy-3-epi-radicinol (ent-32) and 
graphical representation of key NOE contacts; 
arbitrary numbering scheme as shown in the Insert. 
The comparison with the literature data for the 
enantiomer (32) show certain discrepancies, thus 
raising questions as to the original structure assignment of the natural metabolite 
Position 13C NMR 1H NMR 
synthetic 
ent-32 
lit13 for 32 synthetic ent-32 lit13 for 32 
1 166.6 165.4 
2 98.5 99.1 
3 69.7 68.0 4.40 (d, J = 3.8 Hz, 1H) 4.33 (d, J = 3.8 Hz, 1H) 
4 70.0 72.5 3.44 (dd, J = 10.4, 3.5 Hz, 1H) 3.40 (dt, J = 8.2, 3.8 Hz, 1H) 
5 73.2 76.8 4.14 (dq, J = 10.4, 6.4 Hz, 1H) 4.12 (dq, J = 8.2, 6.9 Hz, 1H) 
6 164.3 n.r. 
7 98.8 100.4 5.71 (s, 1H) 5.68 (s, 1H) 
8 159.3 158.9 
9 122.8 122.7 5.95 (dq, J = 15.4, 1.6 Hz, 1H) 5.90 (d, J = 13.9 Hz, 1H) 
10 135.8 135.7 6.73 (dq, J = 15.4, 7.0 Hz, 1H) 6.68 (dq, J = 13.9, 7.5 Hz, 1H) 
11 18.6 18.4 1.90 (dd, J = 7.0, 1.6 Hz, 3H) 1.86 (d, J = 7.5 Hz, 3H) 
12 17.7 17.1 1.48 (d, J = 6.3 Hz, 3H) 1.38 (d, J = 6.9 Hz, 3H) 
13 59.1 55.2 3.61 (s, 3H) 3.65 (s, 3H) 
OH 2.64 (bs, 1H) 2.50 (bs, 1H) 
12
13
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 (+)-3-Methoxy-radicinol (S-13). Prepared analogously starting from 42b (R = Me, 15 mg, 0.04 mmol); 
colorless oil (7.6 mg, 69%). [𝑎]D
20: +40.8 (c = 1, CHCl3). For the NMR-spectroscopic
data, see Table S-2; IR (film): ?̃? = 3402, 2934, 1682, 1659, 1617, 1569, 1427, 1152, 
1084, 1021 cm-1. HRMS (ESI): m/z: calcd. for C13H16O5Na
+: 275.08906; found: 
275.08899. 
Table S-2. Assigned spectral data (CDCl3, 500 MHz/126 
MHz) of 3-methoxy-radicinol (S-13) and graphical 
representation of key NOE contacts; arbitrary 
numbering scheme as shown in the Insert 
Position 13C NMR 1H NMR 
1 164.7 
2 97.6 
3 73.0 4.21 (dd, J = 3.3, 1.5 Hz, 1H) 
4 68.5 4.03 (t, J = 3.3 Hz, 1H) 
5 77.4 4.50 (qdd, J = 7.0, 3.1, 1.7 Hz, 1H) 
6 164.1 
7 99.2 5.72 (s, 1H) 
8 158.9 
9 122.8 5.94 (dq, J = 15.4, 1.6 Hz, 1H) 
10 135.5 6.70 (dq, J = 15.4, 7.0 Hz, 1H) 
11 18.6 1.89 (dd, J = 7.0, 1.6 Hz, 3H) 
12 16.7 1.45 (d, J = 7.1 Hz, 3H) 
13 58.3 3.56 (s, 3H) 
(+)-3-epi-Radicinol (ent-29). BCl3 (1 M in CH2Cl2, 0.17 mL, 0.17 mmol,) was added to a solution of S-11 
(17 mg, 0.05 mmol) in CH2Cl2 (0.5 mL) at –78°C and the resulting mixture was 
stirred for 1.5 h at this temperature. The reaction was quenched with sat. aq. 
NH4Cl and the aqueous layer was extracted with EtOAc. The combined organic 
extracts were washed with brine and dried over MgSO4. The drying agent was 
filtered off and the solvent was evaporated. Purification of the residue by flash chromatography 
(pentanes/EtOAc, 1:1) afforded the title compound as a colorless oil (11 mg, 91%). [𝑎]D
20: +13.0 (c = 1,
CHCl3) [Lit.
14 for 29: [𝑎]D
25: ‒10.7 (c = 0.0014, CHCl3)]. 
1H NMR (400 MHz, CDCl3): δ = 6.71 (dq, J = 15.3, 7.0
Hz, 1H), 5.96 (dq, J = 15.4, 1.4 Hz, 1H), 5.76 (s 1H), 4.76 (d, J = 4.3 Hz, 1H), 4.28 (dq, J = 8.1, 6.6 Hz, 1H), 
3.76 (bs, 1H), 3.65 (dt, J = 7.6, 4.3 Hz, 1H), 2.98 (d, J = 7.3 Hz, 1H), 1.90 (dd, J = 7.1, 1.5 Hz, 3H), 1.45 (d, J 
= 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 165.6, 164.6, 135.9, 122.7, 100.0, 99.1, 74.0, 69.3, 60.9, 
18.6, 17.0. IR (film): ?̃? = 3444, 2924, 2854, 1688, 1572, 1429, 1378, 1262, 1159, 1053 cm-1. HRMS (ESI): 
m/z: calcd. for C12H14O5Na
+: 261.07334; found: 261.07334.  
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 (+)-Radicinol (ent-27). BCl3 (1 M in CH2Cl2, 0.18 mL, 0.18 mmol) was added dropwise to a solution of 
compound 40 (25 mg, 0.06 mmol) in CH2Cl2 (0.6 mL) at ‒78°C and the resulting 
mixture was stirred for 3 h at this temperature. The reaction was quenched with 
sat. aq. NH4Cl and the aqueous layer was extracted with EtOAc. The combined 
extracts were washed with brine and dried over MgSO4. The drying agent was filtered off and the 
solvent was evaporated. Purification of the residue by flash chromatography (pentanes/EtOAc, 1:1) 
afforded the title compound (14 mg, 88%). [𝑎]D
20: +46.9 (c = 1, CHCl3) [Lit.
15 for 27: [𝑎]D
28: ‒92 (c = 0.48,
CHCl3)]. 
1H NMR (400 MHz, CDCl3): δ = 6.71 (dq, J = 15.3, 7.0 Hz, 1H), 5.96 (dq, J = 15.6, 1.6 Hz, 1H), 5.76 
(s, 1H), 4.63 (d, J = 7.6 Hz, 1H), 4.59 (bs, 1H), 4.11 (dq, J = 9.1, 6.5 Hz, 1H), 3.66 (dd, J = 9.5, 7.7 Hz, 1H), 
3.01 (bs, 1H), 1.90 (dd, J = 7.0, 1.6 Hz, 3H), 1.51 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz, CDCl3): δ = 165.1, 
164.2, 158.9, 135.8, 122.6, 100.4, 98.9, 76.3, 73.1, 68.5, 18.6, 17.2. IR (film): ?̃? = 3410, 2953, 2924, 2854, 
1683, 1617, 1570, 1428, 1378, 1277, 1157, 1055, 1019 cm-1. HRMS (ESI): m/z: calcd. for C12H14O5Na
+: 
261.07334; found: 261.07334.  
Preparation of N-Heterocycles 
Compound 53. [(Johnphos)Au]SbF6 (0.005 mmol, 4.0 mg, 5 mol%) was added to a solution of compound 
52 (36 mg, 0.1 mmol) in acetic acid (0.5 mL) and the resulting mixture was stirred for 
24 h. The solvent was distilled off and the residue purified by flash chromatography 
(hexanes/tert-butyl methyl ether, 1:1) to yield the title compound as a white waxy 
solid (24.0 mg, 66%). 1H NMR (400 MHz, CDCl3): δ = 8.31 (d, 1H, J = 7.6 Hz), 7.94 (d, 
2H, J = 8.3 Hz), 7.64 (td, 1H, J = 7.8 and 1.3 Hz), 7.40 (t, 1H, J = 7.8 Hz), 7.30-7.26 (m, 
3H), 6.31 (s, 1H), 2.47 (t, 2H, J = 7.4 Hz), 2.39 (s, 3H), 1.59 (quint, 2H, J = 7.6 Hz), 1.41-1.31 (m, 2H), 0.92 
(t, 3H, J = 7.3 Hz); 13C NMR (100 MHz, CDCl3): δ = 159.9, 157.6, 142.9, 139.3, 135.5, 135.3, 129.1, 128.9, 
128.3, 127.3, 125.1, 120.2, 104.5, 32.4, 28.8, 22.1, 21.5, 13.6; IR (film): ?̃? = 2960, 1703, 1355, 1257, 
1167, 1087, 1034, 814, 703, 658, 569 cm-1; MS (EI) m/z (%): 1088, 733, 378; HRMS (ESI): m/z: calcd. for 
C20H21NO3SNa [M
++Na]: 378.11343, found 378.11378. 
Compound 55. Prepared analogously starting from compound 54 and using MeNO2/water (4:1) as the 
solvent; white solid (54 mg, 80%). Mp = 112-114 °C; D
20][  = +209.3 (c = 0.89, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 8.31 (d, 1H, J = 8.1 Hz), 7.63 (t, 1H, J = 7.6 Hz), 7.47 (d, 
1H, J = 7.9 Hz), 7.41 (t, 1H, J = 8.1 Hz), 7.33-7.30 (m, 2H), 7.26-7.22 (m, 3H), 6.46 (s, 
1H), 5.61 (br. s, 1H), 4.72-4.67 (m, 1H), 4.45 (dd, 1H, J = 12.0, 3.4 Hz), 2.70-2.64 (m, 
2H), 1.65-1.59 (m, 2H), 1.42 (sext, 2H, J = 7.3 Hz), 0.93 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 
164.6, 143.8, 137.2, 136.7, 132.6, 128.5, 127.9, 127.1, 126.2, 126.1, 125.1, 106.8, 64.0, 62.4, 33.7, 31.0, 
22.3, 13.7; IR (film): ?̃? = 3448, 2960, 2928, 2861, 1647, 1617, 1592, 1457, 1378, 1301, 1162, 1046, 988, 
749, 725, 696, 574 cm-1; MS (EI) m/z (%): 322 (5), 321 (14), 303 (10), 274 (5), 262 (9), 261 (39), 260 (7), 
246 (5), 202 (36), 201 (11), 172 (9), 160 (11), 159 (100), 158 (12), 142 (7), 131 (9), 130 (7), 120 (5), 116 
(7), 115 (8), 103 (14), 91 (15), 89 (5), 77 (7), 31 (6); HRMS (ESI): m/z: calcd. for C21H23NO2Na [M
++Na]: 
344.16210, found 344.16195. 
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Representative Procedure for the Synthesis of 1-Alkoxyisoquinolines. 3-Butyl-1-ethoxyisoquinoline 
(58). Triethyloxonium tetrafluoroborate (1.14 g, 6 mmol) was added to a solution of 
2-(hex-1-yn-1-yl)benzamide (1.208 g, 6 mmol) in dichloromethane (30 mL). The 
resulting mixture was stirred overnight and then concentrated. The residue was 
taking up with tert-butyl methyl ether (60 mL) and triethylamine (9 mL) was added 
(if necessary, a little bit of dichloromethane can be added to help solubilize the 
intermediate imidate). The mixture was stirred for 10 min before it was filtered through a plug of cotton 
which was carefully rinsed with tert-butyl methyl ether. The combined filtrates were evaporated and the 
resulting imidate dissolved in chloroform (30 mL). This solution was added to a solution of AgOTs (83.7 
mg, 0.3 mmol, 5 mol%) and DMEDA (26.4 mg, 0.3 mmol, 5 mol%) in chloroform (15 mL) at 0°C. The ice 
bath was removed and the mixture allowed to stir at ambient temperature overnight. The mixture was 
filtered through a plug of silica, which was rinsed with tert-butyl methyl ether. The combined filtrates 
were evaporated and the residue was purified by flash chromatography (hexane/tert-butyl methyl 
ether, 94:4) to afford the title compound as a colorless oil (1.102 g, 80%). 1H NMR (400 MHz, CDCl3): δ = 
8.18 (d, 1H, J = 8.3 Hz), 7.61 (d, 1H, J = 8.0 Hz), 7.55 (td, 1H, J = 6.7, 1.2 Hz), 7.40 (ddd, 1H, J = 8.2, 6.8, 1.3 
Hz), 6.97 (s, 1H), 4.55 (q, 2H, J = 7.1 Hz), 2.74 (t, 2H, J = 7.5 Hz), 1.74 (quint, 2H, J = 7.5 Hz), 1.47 (t, 3H, J = 
7.0 Hz), 1.38 (sext, 2H, J = 7.6 Hz), 0.94 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 159.9, 153.1, 
138.6, 130.0, 125.6, 125.3, 124.1, 118.1, 111.5, 61.6, 37.6, 31.5, 22.4, 14.6, 14.0; IR (film): ?̃? = 2955, 
2929, 2859, 1628, 1572, 1497, 1407, 1376, 1318, 1155, 1104, 1024, 838, 750, 670 cm-1; MS (EI) m/z (%): 
229 (22), 214 (22), 201 (6), 200 (14), 188 (14), 187 (100), 186 (9), 172 (10), 160 (7), 159 (68), 158 (25), 
143 (5), 142 (5), 131 (12), 130 (7), 128 (5), 116 (8), 115 (11), 103 (10), 89 (10), 77 (5), 29 (9), 27 (6); 
HRMS (ESI): m/z: calcd. for C15H20NO [M
++H]: 230.15394, found 230.15413. 
The minor isomer (59) analyzed as follows: colorless oil. 1H NMR (300 MHz, CDCl3): δ = 
7.62 (d, 1H, J = 7.5 Hz), 7.51 (d, 1H, J = 7.4 Hz), 7.37 (td, 1H, J = 7.3, 1.1 Hz), 7.29 (td, 
1H, J = 7.4, 1.0 Hz), 6.16 (t, 1H, J = 7.7 Hz), 4.59 (q, 2H, J = 7.1 Hz), 2.72 (q, 2H, J = 7.4 
Hz), 1.59-1.35 (m, 4H), 1.46 (t, 3H, J = 7.1 Hz), 0.94 (t, 3H, J = 7.2 Hz); 13C NMR (75 
MHz, CDCl3): δ = 170.7, 146.2, 141.5, 131.3, 128.9, 127.0, 124.5, 119.8, 119.1, 64.4, 
31.7, 27.5, 22.4, 14.6, 13.9; IR (film): ?̃? = 2955, 2926, 2857, 1540, 1406, 1377, 1340, 1140, 1091, 1023, 
881, 757, 686 cm-1; MS (EI) m/z (%): 229 (9), 201 (8), 200 (48), 188 (5), 187 (37), 186 (11), 172 (7), 159 
(13), 158 (100), 146 (16), 145 (13), 131 (7), 130 (16), 129 (5), 128 (5), 115 (7), 103 (11), 102 (6), 77 (6), 76 
(5); HRMS (ESI): m/z: calcd. for C15H19NONa [M
++Na]: 252.13588, found 252.13606. 
Colorless oil (33 mg, 77%). 1H NMR (400 MHz, CDCl3): δ = 8.18 (d, 1H, J = 8.2 Hz), 
7.62 (d, 1H, J = 8.0 Hz), 7.57 (t, 1H, J = 7.6 Hz), 7.42 (t, 1H, J = 7.6 Hz), 7.00 (s, 1H), 
4.12 (s, 3H), 2.78 (t, 2H, J = 7.5 Hz), 1.78 (quint, 2H, J = 7.5 Hz), 1.41 (sext, 2H, J = 
7.5 Hz), 0.97 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 160.2, 153.0, 138.6, 
130.1, 125.6, 125.4, 124.0, 118.1, 111.7, 53.4, 37.6, 31.5, 22.4, 14.0; IR (film): ?̃? = 2954, 2858, 1629, 
1573, 1497, 1451, 1367, 1331, 1156, 1101, 986, 839, 750, 670, 556, 524 cm-1; MS (EI) m/z (%): 216 (4), 
215 (21), 200 (7), 186 (8), 174 (12), 173 (100), 172 (8), 158 (24), 131 (4), 115 (5), 103 (4); HRMS (ESI): 
m/z: calcd. for C14H18NO [M
++H]: 216.13829, found 216.13815. 
Colorless oil (34.5 mg, 62%). 1H NMR (400 MHz, CDCl3): δ = 8.20 (d, 1H, J = 8.2 Hz), 
7.60-7.53 (m, 2H), 7.42 (ddd, 1H, J = 8.1, 6.6, 1.5 Hz), 7.28-7.20 (m, 4H), 7.16 (t, 1H, 
J = 7.6 Hz), 6.94 (s, 1H), 4.59 (q, 2H, J = 7.1 Hz), 3.14-3.09 (m, 2H), 3.08-3.03 (m, 
S29 
2H), 1.49 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz, CDCl3): δ = 160.0, 151.7, 142.2, 138.5, 130.1, 128.5, 
128.2, 125.7, 125.6, 125.5, 124.1, 118.3, 111.8, 61.7, 39.6, 35.5, 14.6; IR (film): ?̃? = 2978, 1627, 1572, 
1495, 1408, 1377, 1319, 1154, 1099, 1024, 840, 748, 697, 670 cm-1; MS (EI) m/z (%): 278 (22), 277 (100), 
276 (6), 263 (9), 262 (46), 250 (5), 249 (29), 248 (50), 233 (5), 232 (6), 231 (7), 230 (5), 206 (8), 200 (6), 
186 (27), 172 (9), 171 (5), 159 (5), 158 (39), 145 (6), 142 (8), 140 (5), 131 (21), 130 (6), 115 (13), 103 (20), 
91 (37), 89 (14), 77 (11), 65 (9), 63 (5), 29 (7); HRMS (ESI): m/z: calcd. for C19H20NO [M
++H]: 278.15394, 
found 278.15398. 
Colorless oil (198 mg, 81%). 1H NMR (400 MHz, CDCl3): δ = 7.64 (d, 1H, J = 7.1 Hz), 7.48 
(d, 1H, J = 7.4 Hz), 7.39 (td, 1H, J = 7.4, 1.1 Hz), 7.33 (td, 1H, J = 7.4, 1.0 Hz), 6.24 (s, 1H), 
4.59 (q, 2H, J = 7.1 Hz), 1.48 (t, 3H, J = 7.1 Hz), 0.30 (s, 9H); 13C NMR (100 MHz, CDCl3): δ = 
172.1, 158.7, 141.0, 131.5, 129.1, 127.9, 121.8, 120.3, 119.5, 64.7, 14.5, 0.2; IR (film): ?̃? = 
2954, 1725, 1537, 1406, 1377, 1342, 1322, 1243, 1088, 1011, 836, 759, 689 cm-1; MS (EI) 
m/z (%): 246 (5), 245 (22), 231 (9), 230 (45), 218 (5), 217 (19), 216 (100), 202 (20), 201 
(5), 186 (9), 115 (4), 103 (24), 100 (4), 77 (4), 76 (8), 75 (79), 73 (4), 59 (6), 45 (4); HRMS (ESI): m/z: calcd. 
for C14H20NOSi [M
++H]: 246.13087, found 246.13100. 
Colorless oil (37 mg, 54%). 1H NMR (400 MHz, CDCl3): δ = 8.19 (d, 1H, J = 8.2 Hz), 
7.61 (d, 1H, J = 7.9 Hz), 7.56 (td, 1H, J = 6.7, 1.2 Hz), 7.42 (ddd, 1H, J = 8.2, 6.8, 1.3 
Hz), 6.99 (s, 1H), 4.55 (q, 2H, J = 7.0 Hz), 4.33 (sext, 1H, J = 6.6 Hz), 2.88 (dd, 1H, J = 
13.0, 6.9 Hz), 2.77 (dd, 1H, J = 13.0, 5.8 Hz), 1.47 (t, 3H, J = 7.1 Hz), 1.21 (d, 3H, J = 
6.1 Hz), 0.79 (s, 9H), 0.06 (s, 3H), 0.23 (s, 3H); 13C NMR (100 MHz, CDCl3): δ = 159.9, 149.9, 138.5, 
130.1, 125.6, 125.5, 124.0, 118.2, 113.6, 68.7, 61.6, 48.5, 25.8, 23.9, 18.1, 14.7, 4.8, 5.1; IR (film): ?̃? = 
2954, 2926, 2856, 1629, 1573, 1498, 1409, 1376, 1321, 1253, 1097, 999, 834, 773, 750, 672 cm-1; MS 
(ESI) m/z : 368, 345; HRMS (ESI): m/z: calcd. for C20H32NO2Si [M
++H]: 346.21968, found 346.21927. 
Colorless oil (35 mg, 67%). 1H NMR (400 MHz, CDCl3): δ = 8.30 (d, 1H, J = 8.3 Hz), 7.75 
(d, 1H, J = 8.1 Hz), 7.65 (td, 1H, J = 6.9, 1.2 Hz), 7.56-7.51 (m, 2H), 7.31-7.28 (m, 4H), 
4.62 (q, 2H, J = 7.1 Hz), 2.50 (s, 3H), 1.51 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz, CDCl3): 
δ = 159.6, 150.9, 140.6, 138.4, 136.4, 130.8, 130.3, 129.9, 127.8, 126.3, 126.2, 125.8, 
124.2, 118.4, 114.1, 62.0, 20.9, 14.7; IR (film): ?̃? = 2977, 1625, 1569, 1498, 1406, 
1376, 1319, 1162, 1100, 1023, 931, 875, 847, 752, 725, 666, 534 cm-1; MS (EI) m/z (%): 264 (8), 263 (30), 
248 (8), 235 (20), 234 (100), 232 (7), 218 (5), 217 (6), 216 (16), 204 (6), 189 (5), 178 (4), 89 (5); HRMS 
(ESI): m/z: calcd. for C18H18NO [M
++H]: 264.13829, found 264.13806. 
Colorless oil (40 mg, 81%). 1H NMR (400 MHz, CDCl3): δ = 8.19 (dd, 1H, J = 9.0, 5.8 
Hz), 7.20 (dd, 1H, J = 9.7, 2.5 Hz), 7.13 (td, 1H, J = 8.8, 2.5 Hz), 6.91 (s, 1H), 4.55 
(q, 2H, J = 7.1 Hz), 2.73 (t, 2H, J = 7.6 Hz), 1.75 (quint, 2H, J = 7.4 Hz), 1.47 (t, 3H, J 
= 7.1 Hz), 1.39 (sext, 2H, J = 7.6 Hz), 0.95 (t, 3H, J = 7.3 Hz); 13C NMR (100 MHz, 
CDCl3): δ = 163.6 (d, JC-F = 248.3 Hz), 159.8, 154.6, 140.3 (d, JC-F = 10.2 Hz), 127.1 (d, JC-F = 9.7 Hz), 115.1, 
115.0 (d, JC-F = 24.7 Hz), 111.2 (d, JC-F = 4.1 Hz), 109.1 (d, JC-F = 21.0 Hz), 61.8, 37.6, 31.4, 22.4, 14.6, 14.0; 
19F NMR (282 MHz, CDCl3): δ = 109.4; IR (film): ?̃? = 2956, 2930, 2872, 1633, 1574, 1501, 1407, 1376, 
1322, 1226, 1133, 1105, 1025, 964, 869, 824, 771, 665 cm-1; MS (EI) m/z (%): 248 (8), 247 (21), 232 (21), 
219 (5), 218 (9), 206 (13), 205 (100), 204 (8), 190 (8), 177 (55), 176 (15), 159 (5), 149 (10), 134 (5), 133 
(7), 121 (5), 107 (8); HRMS (ESI): m/z: calcd. for C15H19NOF [M
++H]: 248.14452, found 248.14467. 
S30 
White solid (42 mg, 80%). Mp = 25-26 °C; 1H NMR (400 MHz, CDCl3): δ = 8.10 (d, 
1H, J = 8.8 Hz), 7.57 (d, 1H, J = 2.0 Hz), 7.33 (dd, 1H, J = 8.8, 2.0 Hz), 6.87 (s, 1H), 
4.54 (q, 2H, J = 7.1 Hz), 2.73 (t, 2H, J = 7.5 Hz), 1.74 (quint, 2H, J = 7.4 Hz), 1.47 (t, 
3H, J = 7.1 Hz), 1.38 (sext, 2H, J = 7.6 Hz), 0.95 (t, 3H, J = 7.3 Hz); 13C NMR (100 
MHz, CDCl3): δ = 159.9, 154.7, 139.5, 136.2, 126.1, 125.9, 124.5, 116.3, 110.6, 61.8, 37.6, 31.4, 22.4, 
14.6, 14.0; IR (film): ?̃? = 2978, 2954, 2925, 2870, 1625, 1567, 1474, 1409, 1374, 1315, 1194, 1015, 872, 
829, 772, 664, 594 cm-1; MS (EI) m/z (%): 263 (13), 250 (7), 248 (23), 234 (13), 223 (31), 222 (16), 221 
(100), 220 (12), 206 (12), 195 (28), 194 (16), 193 (84), 192 (22), 190 (5), 177 (7), 175 (5), 167 (6), 166 (5), 
165 (14), 164 (6), 158 (5), 152 (8), 150 (5), 141 (7), 140 (13), 137 (7), 128 (6), 127 (5), 123 (14), 115 (9), 
114 (10), 102 (10), 101 (8), 89 (6), 27 (6); HRMS (ESI): m/z: calcd. for C15H19NOCl [M
++H]: 264.11497, 
found 264.11507. 
White solid (45 mg, 81%). Mp = 51-52 °C; 1H NMR (400 MHz, CDCl3): δ = 8.60-8.56 
(m, 1H), 8.12 (d, 1H, J = 9.0 Hz), 7.91-7.86 (m, 1H), 7.78 (s, 1H), 7.70 (d, 1H, J = 9.0 
Hz), 7.65-7.60 (m, 2H), 4.59 (q, 2H, J = 7.0 Hz), 2.87 (t, 2H, J = 7.6 Hz), 1.82 (quint, 
2H, J = 7.5 Hz), 1.50 (t, 3H, J = 7.1 Hz), 1.42 (sext, 2H, J = 7.6 Hz), 0.96 (t, 3H, J = 
7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 160.3, 155.1, 137.2, 133.7, 128.5, 128.4, 
127.8, 126.3, 125.8, 123.5, 121.2, 114.8, 107.4, 61.8, 38.1, 31.8, 22.5, 14.7, 14.0; IR (film): ?̃? = 2959, 
2926, 1621, 1577, 1515, 1428, 1373, 1327, 1084, 1045, 1027, 825, 756, 740, 556 cm-1; MS (EI) m/z (%): 
280 (9), 279 (40), 265 (5), 264 (26), 251 (7), 250 (9), 238 (18), 237 (100), 236 (8), 222 (8), 209 (42), 208 
(41), 190 (9), 181 (5), 180 (8), 178 (5), 166 (5), 165 (14), 153 (11), 152 (10), 151 (5), 139 (11), 29 (10); 
HRMS (ESI): m/z: calcd. for C19H22NO [M
++H]: 280.16959, found 280.16980. 
White solid (50 mg, 86%). Mp = 58-59 °C; 1H NMR (400 MHz, CDCl3): δ = 7.44 (s, 
1H), 6.90 (s, 1H), 6.86 (s, 1H), 4.54 (q, 2H, J = 7.1 Hz), 3.98 (s, 3H), 3.95 (s, 3H), 
2.70 (t, 2H, J = 7.5 Hz), 1.73 (quint, 2H, J = 7.4 Hz), 1.46 (t, 3H, J = 7.0 Hz), 1.37 
(sext, 2H, J = 7.6 Hz), 0.93 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 158.8, 
152.5, 151.7, 148.6, 134.9, 112.5, 110.7, 104.5, 102.8, 61.4, 55.9, 55.8, 37.4, 31.5, 
22.3, 14.7, 14.0; IR (film): ?̃? = 2954, 2923, 1625, 1578, 1508, 1423, 1316, 1256, 1215, 1164, 1091, 1026, 
860, 774, 642 cm-1; MS (EI) m/z (%): 290 (9), 289 (44), 275 (5), 274 (30), 261 (8), 260 (11), 248 (15), 247 
(100), 246 (10), 232 (7), 219 (24), 218 (72), 204 (6), 174 (6), 29 (7); HRMS (ESI): m/z: calcd. for 
C17H23NO3Na [M
++Na]: 312.15701, found 312.15711. 
This compound is air-sensitive and must be handled with care. No chromatography 
was made for its isolation; rather, the crude material was dissolved in hexane/tert-
butyl methyl ether (95/5) and the solution quickly filtered through a short plug of 
silica. Evaporation of the filtrate gave compound of sufficient purity. The low 
integrals for the two protons of the thiophene core are ascribed to issues with their relaxation time. 
Yellow oil (45 mg, 96%). 1H NMR (400 MHz, CDCl3): δ = 7.98 (dd, 0.6 H, J = 3.2, 1.0 Hz), 7.33 (d, 0.8H, J = 
3.2 Hz), 6.75 (s, 1H), 4.53 (q, 2H, J = 7.1 Hz), 2.62 (t, 2H, J = 7.6 Hz), 1.70 (quint, 2H, J = 7.4 Hz), 1.45 (t, 
3H, J = 7.1 Hz), 1.38 (sext, 2H, J = 7.4 Hz), 0.94 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 156.9, 
150.2, 141.5, 126.0, 120.6, 114.0, 105.6, 61.4, 37.3, 31.2, 22.4, 14.6, 14.1; IR (film): ?̃? = 2956, 2930, 
2859, 1697, 1614, 1525, 1498, 1367, 1311, 1104, 1074, 1019, 861, 831, 804, 751, 732 cm-1; MS (EI) m/z 
(%): 236 (5), 235 (35), 220 (18), 207 (7), 206 (25), 195 (5), 194 (12), 193 (100), 192 (14), 190 (6), 178 (17), 
S31 
177 (6), 166 (10), 165 (89), 164 (47), 149 (6), 148 (6), 137 (25), 136 (5), 124 (5), 122 (13), 121 (7), 109 (8), 
45 (9), 27 (6); HRMS (EI): m/z: calcd. for C13H17NOS [M
+]: 235.10308, found 235.10333. 
Colorless oil (55 mg, 57%). 1H NMR (400 MHz, CDCl3): δ = 6.50 (s, 1H), 6.30 (s, 1H), 
4.28 (q, 2H, J = 7.1 Hz), 2.60 (t, 2H, J = 7.6 Hz), 2.22 (s, 3H), 1.65 (quint, 2H, J = 5.8 Hz), 
1.38-1.29 (m, 2H), 1.35 (t, 3H, J = 7.0 Hz), 0.91 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, 
CDCl3): δ = 163.7, 160.0, 149.8, 116.5, 107.2, 61.4, 37.5, 31.6, 22.4, 20.9, 14.7, 14.0; IR 
(film): ?̃? = 2956, 2930, 2860, 1612, 1568, 1429, 1337, 1214, 1149, 1096, 1058, 835 cm-1; MS (EI) m/z (%): 
193 (3), 178 (34), 164 (14), 151 (100), 150 (10), 136 (12), 123 (70), 77 (7), 67 (4), 53 (10), 41 (6), 27 (6); 
HRMS (ESI): m/z: calcd. for C12H20NO [M
++H]: 194.15393, found 194.15394. 
Colorless oil (101 mg, 79%). 1H NMR (400 MHz, CDCl3): δ = 7.63 (dd, 2H, J = 6.7, 1.5 
Hz), 7.48-7.34 (m, 3H), 6.96 (d, 1H, J = 1.3 Hz), 6.78 (d, 1H, J = 1.3 Hz), 4.44 (q, 2H, J = 
7.0 Hz), 2.77 (t, 2H, J = 7.6 Hz), 1.79 (quint, 2H, J = 7.6 Hz), 1.49-1.40 (m, 2H), 1.45 (t, 
3H, J = 7.0 Hz), 1.00 (t, 3H, J = 7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 164.1, 160.8, 
151.3, 138.9, 128.8, 128.6, 126.9, 113.6, 105.0, 61.5, 37.8, 31.6, 22.4, 14.7, 14.0; IR (film): ?̃? = 2955, 
2929, 2860, 1610, 1553, 1411, 1374, 1339, 1204, 1047, 856, 761, 694, 538 cm-1; MS (EI) m/z (%): 256 (5), 
255 (7), 240 (21), 226 (10), 214 (15), 213 (100), 198 (6), 185 (34), 167 (5), 156 (6), 115 (8); HRMS (ESI): 
m/z: calcd. for C17H22NO [M
++H]: 256.16958, found 256.16968.  
Colorless oil (66 mg, 62%). 1H NMR (400 MHz, CDCl3): δ = 8.04 (d, 2H, J = 7.1 Hz), 7.44 (t, 
2H, J = 7.6 Hz), 7.38 (t, 1H, J = 7.2 Hz), 7.16 (s, 1H), 6.50 (s, 1H), 4.49 (q, 2H, J = 7.1 Hz), 
2.34 (s, 3H), 1.44 (t, 3H, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3): δ = 163.8, 154.3, 150.1, 
139.2, 128.5, 128.4, 126.6, 114.2, 109.4, 61.3, 21.0, 14.7; IR (film): ?̃? = 2978, 1610, 1563, 
1430, 1411, 1380, 1336, 1227, 1155, 1052, 836, 771, 691, 561 cm-1; MS (EI) m/z (%): 214 
(11), 213 (40), 212 (6), 199 (14), 198 (100), 186 (4), 185 (32), 184 (7), 170 (5), 169 (21), 168 (21), 167 (4), 
157 (17), 156 (23), 154 (10), 141 (4), 129 (5), 128 (8), 127 (4), 115 (6), 84 (6), 77 (5), 53 (6), 51 (6), 49 (7), 
29 (5), 27 (5); HRMS (EI): m/z: calcd. for C14H15NO [M
+]: 213.11536, found 213.11510. 
Colorless oil (55 mg, 56%). 1H NMR (400 MHz, CDCl3): δ = 7.72 (dd, 1H, J = 8.1, 7.4 Hz), 
6.65 (d, 1H, J = 7.2 Hz), 6.48 (d, 1H, J = 8.2 Hz), 4.31 (q, 2H, J = 7.1 Hz), 2.65 (t, 2H, J = 7.6 
Hz), 2.65 (quint, 2H, J = 7.4 Hz), 1.40-1.30 (m, 2H), 1.37 (t, 3H, J = 7.0 Hz), 0.91 (t, 3H, J = 
7.4 Hz); 13C NMR (100 MHz, CDCl3): δ = 163.4, 160.4, 138.6, 114.9, 107.1, 61.4, 37.6, 
31.6, 22.4, 14.7, 14.0; IR (film): ?̃? = 2956, 2930, 2860, 1595, 1578, 1446, 1282, 1258, 1042, 988, 789 cm-1; 
MS (EI) m/z (%): 179 (4), 165 (4), 164 (28), 151 (4), 150 (13), 137 (100), 136 (11), 135 (6), 134 (4), 123 (4), 
122 (16), 109 (85), 106 (8), 104 (8), 93 (7), 92 (6), 91 (17), 81 (8), 80 (12), 79 (5), 77 (7), 66 (7), 65 (8), 53 
(8), 41 (5), 39 (12), 29 (5), 27 (6); HRMS (EI): m/z: calcd. for C11H17NO [M
+]: 179.13101, found 179.13107. 
Representative Procedure for the Deprotection.16 Preparation of 3-Butylisoquinolin-1(2H)-one. An 
aliquot of a stock solution of TMSCl (3.4 mL, 0.26 mmol) [50 μL of TMSCl in 5 mL of 
MeCN] was added to a solution of 3-butyl-1-ethoxyisoquinoline (46 mg, 0.2 mmol) 
and NaI (30 mg, 0.2 mmol) in MeCN (13 mL). The resulting mixture is stirred for 2 h 
at reflux temperature. Additional NaI (15 mg, 0.1 mmol) and TMSCl (16 μL, 0.13 mmol) were added and 
heating continued for additional 30 min. After reaching ambient temperature, the reaction was 
quenched with water and the aqueous layer repeatedly extracted with EtOAc. The combined extracts 
16
C. González, E. Guitián, L. Castedo, Tetrahedron 1999, 55, 5195‒5206. 
S32 
were washed with water, aq. Na2S2O3 (10 mol%) and brine before they were dried over MgSO4 and 
evaporated to give the title compound (41 mg, quant.). The spectroscopic data were in good agreement 
with those reported in the literature.17 
Double Cyclization 
Methyl deca-2,9-diynoate. A solution of MeMgCl in THF (2.76 M, 5.8 mL, 16 mmol) was added dropwise 
to a solution of 1,8-nonadiyne (2.40 mL, 16.0 mmol) in THF (80 mL) at 20°C. 
The cold bath was removed and the mixture stirred for 5 h at room 
temperature before it was cooled again to 20°C. Methyl chloroformate (80 
mmol, 6.2 mL) was added and stirring continued for 1 h at ambient temperature. The reaction was 
quenched with aq. sat. NH4Cl, the aqueous layer was extracted with tert-butyl methyl ether and the 
combined extracts were washed with water and brine before they were dried (Na2SO4) and 
concentrated. Purification of the residue by flash chromatography (hexanes/tert-butyl methyl ether, 
85:15) gave the title compound as a colorless oil (1.48 g, 52%). 1H NMR (400 MHz, CDCl3): δ = 3.69 (s, 
3H), 2.29 (t, 2H, J = 6.8 Hz), 2.16-2.12 (m, 2H), 1.89 (t, 1H, J = 2.6 Hz), 1.58-1.44 (m, 6H); 13C NMR (100 
MHz, CDCl3): δ = 154.1, 89.3, 84.0, 72.9, 68.4, 52.4, 27.8, 27.7, 26.9, 18.4, 18.1; IR (film): ?̃? = 3294, 2942, 
2864, 2236, 1710, 1434, 1249, 1076, 752, 634 cm-1; MS (EI) m/z (%): 149 (5), 147 (5), 135 (9), 119 (20), 
118 (9), 117 (43), 115 (7), 111 (6), 107 (10), 105 (20), 103 (8), 93 (7), 92 (11), 91 (100), 81 (25), 79 (67), 
77 (37), 69 (5), 68 (6), 67 (14), 66 (26), 65 (13), 59 (21), 55 (16), 53 (39), 51 (18), 41 (51), 39 (47), 38 (6), 
29 (8), 27 (14); HRMS (ESI): m/z: calcd. for C11H14O2Na [M
++Na]: 201.08860, found 201.08870. 
Compound 63. A solution of 2-iodobenzamide (1.065 g, 4.3 mmol), triethylamine (2.40 mL, 17.2 mmol), 
PdCl2(PPh3)2 (106 mg, 0.15 mmol, 3.5 mol%) and copper iodide (66 mg, 
0.08 mmol, 8 mol%) in DMF (16 mL) was stirred for 1 h before a 
solution of methyl deca-2,9-diynoate (922 mg, 5.17 mmol) in DMF (4.0 
mL + 1.5 mL for rinsing) was added. The resulting mixture was stirred 
for 4 d. For work up, the mixture was poured into water, the aqueous phase was repeatedly extracted 
with EtOAc, and the combined extracts were washed with water and brine before they were dried 
(Na2SO4) and concentrated. Purification of the residue by flash chromatography (tert-butyl methyl 
ether/hexanes, 95:5) furnished the title compound as a yellow solid (932 mg, 73%). Mp = 63-64°C; 1H 
NMR (400 MHz, CDCl3): δ = 7.47-7.43 (dd, 1H, J = 6.8, 2.5 Hz), 7.53 (br. s, 1H), 7.49-7.45 (dd, 1H, J = 6.6, 
2.4 Hz), 7.41-7.34 (m, 2H), 6.01 (br. s, 1H), 3.72 (s, 3H), 2.49 (t, 2H, J = 6.6 Hz), 2.36 (t, 2H, J = 6.4 Hz), 
1.66-1.55 (m, 6H); 13C NMR (100 MHz, CDCl3): δ = 168.2, 154.1, 134.2, 133.8, 130.9, 130.1, 128.1, 120.8, 
97.0, 89.3, 79.9, 73.1, 52.6, 28.0, 27.8, 26.9, 19.5, 18.5; IR (film): ?̃? = 3361, 3171, 2943, 2233, 1707, 1637, 
1594, 1450, 1398, 1252, 1076, 815, 779, 749, 631 cm-1; MS (EI) m/z (%): 239 (7), 238 (25), 237 (5), 236 
(7), 224 (13), 223 (11), 222 (13), 221 (22), 220 (11), 219 (8), 210 (7), 209 (10), 208 (11), 207 (8), 205 (6), 
203 (8), 200 (18), 196 (12), 195 (14), 194 (15), 193 (13), 192 (6), 191 (8), 183 (8), 182 (10), 181 (14), 180 
(12), 179 (8), 178 (13), 173 (5), 172 (26), 168 (5), 167 (8), 166 (8), 165 (24), 160 (9), 159 (100), 158 (26), 
155 (11), 154 (7), 153 (9), 152 (8), 146 (8), 144 (5), 143 (6), 141 (9), 140 (12), 133 (7), 132 (6), 131 (7), 
130 (42), 129 (8), 128 (16), 127 (17), 126 (5), 117 (5), 116 (7), 115 (29), 114 (13), 113 (6), 105 (9), 104 
(12), 103 (19), 102 (9), 101 (7), 91 (9), 89 (7), 88 (6), 79 (11), 77 (29), 75 (5), 66 (8), 65 (6), 63 (8), 55 (7), 
53 (8), 52 (6), 51 (9), 44 (8), 43 (7), 41 (6), 39 (10), 29 (8); HRMS (ESI): m/z: calcd. for C18H19NO3Na 
[M++Na]: 320.12571, found 320.12572. 
17
H. Gao, J. Zhang, Adv. Synth. Catal. 2009, 351, 85‒88. 
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Compound 65. tert-Butyl acetate (176 μL, 1.3 mmol) was added to a freshly prepared solution of LDA 
(1.0 M in THF, 1.2 mL, 1.2 mmol) at 78°C. The mixture was stirred for 
30 min at this temperature before a solution of compound 63 (149 mg, 
0.5 mmol) in THF (1.2 mL) was added dropwise. Stirring was continued 
for 4 h at 78°C. The reaction was quenched with aq. sat. NH4Cl and 
the aqueous phase extracted with tert-butyl methyl ether. The combined extracts were washed with 
water and brine before they were dried (Na2SO4) and gently concentrated. The resulting product is 
instable; attempted chromatography (silica) results in extensive degradation. The product should be 
carefully handled and directly used in the next step. 
Triethyloxonium tetrafluoroborate (95 mg, 0.5 mmol) was added to a solution of the crude material in 
dichloromethane (2.5 mL). The mixture was stirred for 2 h before triethylamine (70 μL, 0.5 mmol) and 
ether (1.0 mL) were added. After 5 min, the mixture was filtered through a plug of silica, which was 
carefully rinsed with tert-butyl methyl ether. The combined filtrates were concentrated and the residue 
dissolved in chloroform (1.0 mL). 
This solution of the crude imidate was added at 0°C to a solution of AgOTs (14 mg, 0.05 mmol, 10 mol%) 
and DMEDA (5.4 μL, 0.05 mmol, 10 mol%) in chloroform (1.0 mL + 0.5 for rising). The ice bath was 
removed and the mixture stirred overnight before it was filtered through a plug of silica that was 
carefully rinsed with tert-butyl methyl ether. The combined filtrates were concentrated and the residue 
purified by flash chromatography (tert-butyl methyl ether/CH2Cl2, 4:1) to give the title compound as a 
pale yellow oil (137 mg, 67%). At this stage, trace amounts of an inseparable impurity were present 
which could be removed in the next step. 1H NMR (300 MHz, CDCl3): δ = 8.18 (d, 1H, J = 8.2 Hz), 7.62-
7.53 (m, 2H), 7.41 (ddd, 1H, J = 8.2, 6.5, 1.6 Hz), 6.95 (s, 1H), 5.98 (d, 1H, J = 1.9 Hz), 5.55 (d, 1H, J = 2.0 
Hz), 4.54 (q, 2H, J = 7.1 Hz), 2.73 (t, 2H, J = 7.4 Hz), 2.46 (t, 2H, J = 7.5 Hz), 1.80 (quint, 2H, J = 7.6 Hz), 
1.73-1.63 (m, 2H), 1.49-1.40 (m, 14H); 13C NMR (75 MHz, CDCl3): δ = 182.4, 165.7, 165.5, 160.0, 152.3, 
138.5, 130.1, 125.5, 125.4, 124.0, 118.2, 112.4, 111.6, 98.2, 85.3, 61.6, 37.5, 33.1, 28.8, 28.6, 28.4, 26.6, 
14.6; IR (film): ?̃? = 2979, 2932, 2859, 1657, 1626, 1572, 1372, 1320, 1247, 1137, 1101, 1023, 930, 840, 
753, 671 cm-1; MS (EI) m/z (%): 411 (5), 410 (29), 409 (97), 294 (6), 353 (8), 352 (9), 338 (8), 335 (9), 324 
(19), 310 (6), 289 (5), 238 (7), 228 (14), 215 (12), 214 (9), 212 (5), 201 (18), 200 (92), 198 (13), 188 (13), 
187 (100), 186 (26), 185 (6), 184 (14), 173 (8), 172 (32), 171 (10), 167 (8), 160 (5), 159 (42), 158 (31), 154 
(10), 143 (6), 142 (5), 141 (5), 131 (11), 130 (5), 116 (5), 115 (7), 103 (7), 69 (9), 57 (51), 41 (9), 29 (12); 
HRMS (ESI): m/z: calcd. for C25H31NO4Na [M
++Na]: 432.21453, found 432.21482. 
Compound 67. An aliquot of a stock solution of TMSCl (5.3 mL, 0.84 mmol, 2.6 eq) [200 μL of TMSCl in 
10 mL of MeCN] was added to a solution of compound 63 (132 mg, 0.32 mmol) and NaI (96 mg, 0.64 
mmol) in MeCN (21 mL). The mixture was then stirred for 3 h at reflux temperature. After reaching 
ambient temperature, the reaction was quenched with water and the aqueous layer was repeatedly 
extracted with EtOAc. The combined extracts were successively washed with water, aq. Na2S2O3 (10 
mol%) and water.  
The insoluble material was filtered off, and the organic phase was 
concentrated. The residue was dried in high vacuum for 1 h before it was 
suspended in CH2Cl2 (28 mL). Triethylamine (1.82 mL, 13.0 mmol) was 
added at 0°C, followed by propionic anhydride (1.26 mL, 9.8 mmol). The 
mixture was stirred for 3 h at this temperature before water was 
S34 
 
introduced. The aqueous layer was repeatedly extracted with CH2Cl2, the combined organic phases were 
washed with water and brine, dried (Na2SO4) and concentrated. The crude material still contained 
anhydride which was pumped off in high vacuum before the residue was purified by flash 
chromatography (EtOAc/tert-butyl methyl ether, 4:1) to give the title compound as a yellow solid (95 
mg, 77%), Mp = 130-131°C. 1H NMR (400 MHz, CDCl3): δ = 11.44 (br. s, 1H), 8.32 (d, 1H, J = 8.0 Hz), 7.59 
(t, 1H, J = 7.2 Hz), 7.46 (d, 1H, J = 7.6 Hz), 7.40 (t, 1H, J = 7.9 Hz), 6.29 (s, 1H), 6.01 (d, 1H, J = 2.0 Hz), 5.89 
(d, 1H, J = 2.0 Hz), 2.63 (t, 2H, J = 7.5 Hz), 2.54-2.46 (m, 4H), 1.78 (quint, 2H, J = 7.6 Hz), 1.71 (quint, 2H, J 
= 7.6 Hz), 1.45 (quint, 2H, J = 7.1 Hz), 1.19 (t, 3H, J = 7.5 Hz); 13C NMR (100 MHz, CDCl3): δ = 170.5, 166.6, 
163.8, 163.1, 141.6, 138.7, 132.6, 127.1, 125.8, 125.7, 104.0, 101.0, 100.7, 33.6, 33.1, 28.2, 27.9, 27.8, 
26.3, 8.6; IR (film): ?̃? = 2920, 1781, 1712, 1638, 1567, 1462, 1345, 1164, 1100, 1068, 855, 800, 762, 688, 
580, 469 cm-1; MS (EI) m/z (%): 382 (18), 381 (38), 326 (10), 325 (33), 200 (13), 198 (5), 187 (17), 186 (8), 
184 (5), 173 (22), 172 (100), 171 (8), 160 (11), 159 (96), 158 (17), 131 (10), 103 (6), 89 (5), 69 (6), 57 (27), 
29 (20), 27 (5); HRMS (ESI): m/z: calcd. for C22H23NO5Na [M+Na
+]: 404.14684, found 404.14688. 
Compound 66. A solution of boron tribromide (1.0 M, 0.62 mmol, 624 μL) was added to a solution of 
compound 65 (64 mg, 0.16 mmol) in CH2Cl2 (4.7 mL) at 0°C. The ice bath 
was removed and the mixture stirred for 1 d at ambient temperature. The 
reaction was quenched at 0°C with water and the aqueous layer was 
repeatedly extracted with CH2Cl2. The combined extracts were washed 
with water and brine, dried (Na2SO4) and concentrated. The residue was 
dissolved in CH2Cl2 (11 mL). Triethylamine (344 μL, 2.5 mmol) was added at 0°C followed by propionic 
anhydride (172 μL, 1.3 mmol). The mixture was stirred overnight while reaching ambient temperature. 
The reaction was carefully quenched with aq. sat. NaHCO3 and the aqueous layer extracted with CH2Cl2. 
The combined organic phases were washed with water and brine, dried (Na2SO4) and concentrated. 
Excess anhydride was pumped off in vacuum before the residue was purified by flash chromatography 
(tert-butyl methyl ether/hexane, 3:2) to give the title compound as a yellow solid (24 mg, 38%), Mp = 
68-70 °C. 1H NMR (400 MHz, CDCl3): δ = 8.17 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 8.0 Hz), 7.46 (ddd, 1H, J = 
8.0, 6.7, 1.2 Hz), 7.41 (ddd, 1H, J = 8.2, 6.8, 1.4 Hz), 6.95 (s, 1H), 6.01 (d, 1H, J = 2.0 Hz), 5.89 (d, 1H, J = 
2.0 Hz), 4.54 (q, 2H, J = 7.1 Hz), 2.73 (t, 2H, J = 7.4 Hz), 2.53 (q, 2H, J = 7.5 Hz), 2.47 (t, 2H, J = 7.7 Hz), 
1.79 (quint, 2H, J = 7.6 Hz), 1.70 (quint, 2H, J = 7.7 Hz), 1.48-1.39 (m, 2H), 1.47 (t, 3H, J = 7.0 Hz), 1.21 (t, 
3H, J = 7.6 Hz); 13C NMR (100 MHz, CDCl3): δ = 170.5, 167.0, 163.8, 163.1, 159.9, 152.4, 138.5, 130.1, 
125.6, 125.4, 124.0, 118.2, 111.6, 100.9, 100.5, 61.6, 37.4, 33.8, 28.7, 28.5, 27.8, 26.5, 14.6, 8.6; IR (film): 
?̃? = 2937, 2862, 2360, 1774, 1714, 1640, 1570, 1404, 1381, 1336, 1317, 1149, 1088, 1071, 1026, 854, 
834, 759, 675 cm-1; MS (ESI) m/z: 841, 432; HRMS (ESI): m/z: calcd. for C24H27NO5Na [M
++Na]: 
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